{"content":"<li class=\"n-box-item date-title\" data-end=\"1524023999\" data-start=\"1523937600\" data-txt=\"Monday, December 23, 2019\">Tuesday, April 17, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3346323\" data-ts=\"1524006306\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346323-tesla-to-push-for-6000-model-3-cars-per-week-end-june-musk-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla to push for 6,000 Model 3 cars per week by end-June, Musk says</a></h4><ul>     <li>Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) <font color='green'>+2.2%</font> after-hours following a report that Model 3 production is expected to <a href=\"https://www.bloomberg.com/news/articles/2018-04-17/tesla-moves-to-24-7-model-3-production-to-hit-6-000-a-week-goal\" target=\"_blank\">climb to 6K cars per week</a> by the end of June, according to an <a href=\"https://electrek.co/2018/04/17/tesla-model-3-production-goal-6000-units-per-week/\" target=\"_blank\">internal email</a> obtained by automotive news website Electrek.</li>     <li>&ldquo;As part of the drive towards 6K, all Model 3 production at Fremont will move to 24/7 operations. This means that we will be adding another shift to general assembly, body and paint,&rdquo; CEO Elon Musk wrote, adding that TSLA would hire ~400 people per week for several weeks.</li>     <li>TSLA had said previously that it was targeting 5K Model 3 cars per a week by the end of Q2, but \"we cannot have a number with no margin for error,\" Musk said.</li>     <li>Musk also said TSLA will be &ldquo;far more rigorous&rdquo; about expenditures, with any expenses or sets of related expenses that reach more than $1M to be on hold until he &ldquo;explicitly&rdquo; approves.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346323\" data-linked=\"Tesla to push for 6,000 Model 3 cars per week by end-June, Musk says\" data-tweet=\"$TSLA - Tesla to push for 6,000 Model 3 cars per week by end-June, Musk says https://seekingalpha.com/news/3346323-tesla-to-push-for-6000-model-3-cars-per-week-end-june-musk-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3346323-tesla-to-push-for-6000-model-3-cars-per-week-end-june-musk-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>765&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346319\" data-ts=\"1524004392\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLCM\" target=\"_blank\">BLCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346319-bellicum-prices-offering-7_50-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bellicum prices offering at $7.50/share</a></h4><ul>   <li>Bellicum Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/BLCM' title='Bellicum Pharmaceuticals'>BLCM</a>) has <a href=\"https://seekingalpha.com/pr/17132693-bellicum-pharmaceuticals-announces-pricing-public-offering-common-stock\" target=\"_blank\">priced an upsized 8M-share offering</a> at $7.50 each.</li>    <li>That makes for a gross raise of $60M. Underwriters have a 30-day option to buy up to 1.2M more shares at the offering price.</li>    <li>Shares had <font color='red'>fallen 12.6%</font> during the regular session today to close at $7.84; they're <font color='green'>up 2%</font> after hours at last check, to $8.00.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3345986-bellicum-pharmaceuticals-minus-6_9-percent-7m-share-public-offering\" target=\"_blank\">Bellicum Pharmaceuticals -6.9% on 7M-share public offering</a> (Apr. 16 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346319\" data-linked=\"Bellicum prices offering at $7.50/share\" data-tweet=\"$BLCM - Bellicum prices offering at $7.50/share https://seekingalpha.com/news/3346319-bellicum-prices-offering-7_50-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3346319-bellicum-prices-offering-7_50-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346317\" data-ts=\"1524003041\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBII\" target=\"_blank\">MBII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346317-marrone-bio-innovationsminus-4_9-on-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marrone Bio Innovations -4.9% on share offering</a></h4><ul>   <li>Marrone Bio Innovations (NASDAQ:<a href='https://seekingalpha.com/symbol/MBII' title='Marrone Bio Innovations, Inc.'>MBII</a>) is <font color='red'>4.9% lower</font> after hours on news that it's planning a <a href=\"https://seekingalpha.com/pr/17132571-marrone-bio-innovations-inc-announces-proposed-public-offering-common-stock\" target=\"_blank\">public offering of shares</a>.</li>    <li>The underwriter is expected to get a 45-day option to buy up to an additional 15% of shares for overallotments.</li>    <li>National Securities is the sole book-runner.</li>    <li>Marrone Bio will use net proceeds for general purposes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346317\" data-linked=\"Marrone Bio Innovations -4.9% on share offering\" data-tweet=\"$MBII - Marrone Bio Innovations -4.9% on share offering https://seekingalpha.com/news/3346317-marrone-bio-innovationsminus-4_9-on-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3346317-marrone-bio-innovationsminus-4_9-on-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346316\" data-ts=\"1524002979\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETH\" target=\"_blank\">ETH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346316-ethan-allen-expects-q3-earnings-to-fall-short-of-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ethan Allen expects Q3 earnings to fall short of estimates</a></h4><ul>     <li>Ethan Allen (NYSE:<a href='https://seekingalpha.com/symbol/ETH' title='Ethan Allen Interiors Inc.'>ETH</a>) <font color='red'>-3.5%</font> after-hours as it warns higher marketing costs and delayed deliveries <a href=\"https://www.sec.gov/Archives/edgar/data/896156/000143774918007027/ex_110511.htm\" target=\"_blank\">will hurt its FQ3 results</a>, to be released later this month.</li>     <li>ETH says it sees Q3 EPS of $0.10-$0.11 vs  $0.16 analyst consensus estimate with revenues of $181.4M, +0.5% Y/Y and in line with consensus Estimate.</li>     <li>ETH says the results reflect \"an increase in marketing expenditures, the delayed delivery of the retail backlog while manufacturing caught up on production, increases in raw materials costs, higher insurance costs, and manufacturing inefficiencies due to the startup of the government contract.\"</li>     <li>As previously reported, ETH expects Q3 retail division written orders rose 2.6% with strong acceleration in March increasing 6.9% over the prior year.</li>     <li>The company also says it resumed buying back shares in the open market earlier this month, so far repurchasing ~300K shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346316\" data-linked=\"Ethan Allen expects Q3 earnings to fall short of estimates\" data-tweet=\"$ETH - Ethan Allen expects Q3 earnings to fall short of estimates https://seekingalpha.com/news/3346316-ethan-allen-expects-q3-earnings-to-fall-short-of-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3346316-ethan-allen-expects-q3-earnings-to-fall-short-of-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346312\" data-ts=\"1524001007\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLGT\" target=\"_blank\">TLGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346312-after-hours-gainers-losers-04-17-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (04/17/2018)</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/TLGT' title='Teligent, Inc.'>TLGT</a> <font color='green'>+12.6%</font>. <a href='https://seekingalpha.com/symbol/ISRG' title='Intuitive Surgical, Inc.'>ISRG</a> <font color='green'>+5.7%</font>. <a href='https://seekingalpha.com/symbol/CSX' title='CSX Corporation'>CSX</a>&nbsp;<font color='green'>+3.7%</font>. <a href='https://seekingalpha.com/symbol/UAL' title='United Continental Holdings, Inc'>UAL</a>&nbsp;<font color='green'>+2.9%</font>. <a href='https://seekingalpha.com/symbol/STG' title='Sunlands Online Education'>STG</a>&nbsp;<font color='green'>+1.6%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/INFN' title='Infinera Corporation'>INFN</a> <font color='red'>-5.2%</font>. <a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a> <font color='red'>-5.3%</font>. <a href='https://seekingalpha.com/symbol/BMI' title='Badger Meter, Inc.'>BMI</a>&nbsp;<font color='red'>-5.0%.&nbsp;</font><a href='https://seekingalpha.com/symbol/SJI' title='South Jersey Industries Inc.'>SJI</a>&nbsp;<font color='red'>-4.1%</font>. <a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a>&nbsp;<font color='red'>-4.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346312\" data-linked=\"After Hours Gainers / Losers (04/17/2018)\" data-tweet=\"$TLGT $TLGT $ISRG - After Hours Gainers / Losers (04/17/2018) https://seekingalpha.com/news/3346312-after-hours-gainers-losers-04-17-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3346312-after-hours-gainers-losers-04-17-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346291\" data-ts=\"1523998200\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346291-ibm-reports-q1-beats-fy-profit-guidance-miss-sharesminus-5_1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM reports Q1 beats, FY profit guidance miss; shares -5.1%</a></h4><ul><li>        IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) shares&nbsp;<font color='red'>drop 5.1%</font>&nbsp;aftermarket following Q1 results that beat EPS and revenue estimates. FY18 guidance reiterated with EPS of at least $13.80 (consensus: $13.84) and FCF of $12B.&nbsp;&nbsp;</li><li>        Segment performance: Cognitive Solutions (solutions and transaction processing software), $4.3B (+2% in constant currency) ; Global Business Services (consulting, global process services, and application management), $4.2B (-1%) ; Technology Services &amp; Cloud Platform (infrastructure services, tech support services, integration hardware), $8.6B (-1%) ; Systems (systems hardware and OS software), $1.5B (+4%) ; Global Financing (financing and used equipment sales), $405M (-4%).&nbsp; &nbsp;</li><li>        Strategic imperatives and cloud: Revenue was up 10% (constant currency) to $37.7B in the last 12 months. Total cloud revenue was up 20% to $17.7B. The annual exit run rate for as-a-service revenue increased 20% to $10.7B. &nbsp;</li><li>        Financials: Cash from operating activities, $4.6B (including Global Financing receivables); FCF, $1.3B; cash on hand, $13.2B; debt, $46.4B (including Global Financing debt of $31.7B).</li><li>               Investor returns: IBM returned $2.2B to shareholders through $1.4B in dividends and $0.8B in share repurchases.&nbsp;</li><li>               IBM&rsquo;s earnings call is scheduled for 5 PM Eastern with a webcast available <a href=\"https://www.ibm.com/investor/events/earnings/1q18.html\" target=\"_blank\">here.</a>&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17132514-ibm-reports-2018-first-quarter-results\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346255-international-business-machines-beats-0_06-beats-revenue\" target=\"_blank\">International Business Machines beats by $0.06, beats on revenue</a> (April 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346291\" data-linked=\"IBM reports Q1 beats, FY profit guidance miss; shares -5.1%\" data-tweet=\"$IBM - IBM reports Q1 beats, FY profit guidance miss; shares -5.1% https://seekingalpha.com/news/3346291-ibm-reports-q1-beats-fy-profit-guidance-miss-sharesminus-5_1?source=tweet\" data-url=\"https://seekingalpha.com/news/3346291-ibm-reports-q1-beats-fy-profit-guidance-miss-sharesminus-5_1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346289\" data-ts=\"1523998104\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLGT\" target=\"_blank\">TLGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346289-fda-oks-teligents-generic-clobetasol-cream-shares-up-20-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Teligent&#39;s generic clobetasol cream; shares up 20% after hours</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17132598-teligent-inc-announces-fda-approval-clobetasol-propionate-cream-usp-0_05-percent\" target=\"_blank\">approves </a>Teligent's (NASDAQ:<a href='https://seekingalpha.com/symbol/TLGT' title='Teligent, Inc.'>TLGT</a>) generic Clobetasol Propionate Cream USP, 0.05%.</li><li>Per IQVIA, the U.S. market is ~$125M.</li><li>Shares are up&nbsp;<font color='green'>20%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346289\" data-linked=\"FDA OKs Teligent&#39;s generic clobetasol cream; shares up 20% after hours\" data-tweet=\"$TLGT - FDA OKs Teligent&#39;s generic clobetasol cream; shares up 20% after hours https://seekingalpha.com/news/3346289-fda-oks-teligents-generic-clobetasol-cream-shares-up-20-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3346289-fda-oks-teligents-generic-clobetasol-cream-shares-up-20-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346284\" data-ts=\"1523997575\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGLE\" target=\"_blank\">AGLE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346284-aeglea-bio-readies-stock-offering-shares-down-10-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aeglea Bio readies stock offering; shares down 10% after hours</a></h4><ul><li>Aeglea BioTherapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AGLE' title='Aeglea BioTherapeutics'>AGLE</a>) launches a <a href=\"https://seekingalpha.com/pr/17132464-aeglea-biotherapeutics-announces-proposed-public-offering-common-stock\" target=\"_blank\">public offering </a>of 4.5M shares of common stock. Price and terms have yet to be announced.</li><li>Shares are down&nbsp;<font color='red'>10%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346284\" data-linked=\"Aeglea Bio readies stock offering; shares down 10% after hours\" data-tweet=\"$AGLE - Aeglea Bio readies stock offering; shares down 10% after hours https://seekingalpha.com/news/3346284-aeglea-bio-readies-stock-offering-shares-down-10-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3346284-aeglea-bio-readies-stock-offering-shares-down-10-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346282\" data-ts=\"1523997461\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SJI\" target=\"_blank\">SJI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346282-south-jersey-industries-plans-stock-equity-units-offerings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">South Jersey Industries plans stock, equity units offerings</a></h4><ul>     <li>South Jersey Industries (NYSE:<a href='https://seekingalpha.com/symbol/SJI' title='South Jersey Industries Inc.'>SJI</a>) <font color='red'>-4%</font> after-hours as it announces plans to conduct <a href=\"https://www.streetinsider.com/Press+Releases/SJI+news+release%3A+SOUTH+JERSEY+INDUSTRIES%2C+INC.+ANNOUNCES+PROPOSED+COMMON+STOCK+AND+EQUITY+UNITS+OFFERINGS/14064659.html\" target=\"_blank\">concurrent public offerings</a> of as much as $325M of common shares and 5M equity units.</li>     <li>SJI expects to grant the underwriters an option to purchase up to an additional $48.75M of shares and up to an additional 750K equity units.</li>     <li>SJI says the proceeds from the offerings will be used to help fund the pending acquisitions of Elizabethtown Gas and Elkton Gas, which are expected to close in mid-year 2018.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346282\" data-linked=\"South Jersey Industries plans stock, equity units offerings\" data-tweet=\"$SJI - South Jersey Industries plans stock, equity units offerings https://seekingalpha.com/news/3346282-south-jersey-industries-plans-stock-equity-units-offerings?source=tweet\" data-url=\"https://seekingalpha.com/news/3346282-south-jersey-industries-plans-stock-equity-units-offerings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346280\" data-ts=\"1523997275\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CATB\" target=\"_blank\">CATB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346280-catabasis-to-cut-workforce-42-in-restructuring-move-shares-down-6-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catabasis to cut workforce 42% in restructuring move; shares down 6% after hours</a></h4><ul><li>Aimed at extending its cash runway as it focuses its resources on Duchenne muscular dystrophy &#40;DMD&#41; candidate edasalonexent, Catabasis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CATB' title='Catabasis Pharmaceuticals'>CATB</a>) will <a href=\"https://seekingalpha.com/pr/17132461-catabasis-pharmaceuticals-aligns-resources-focus-lead-program-edasalonexent-treatment\" target=\"_blank\">restructure </a>its operations, cutting its workforce by 42% and saving ~$3.3M in annualized personnel costs. It will record ~$1M charge this quarter related to the costs of the initiative.</li><li>Shares are down&nbsp;<font color='red'>6%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346280\" data-linked=\"Catabasis to cut workforce 42% in restructuring move; shares down 6% after hours\" data-tweet=\"$CATB - Catabasis to cut workforce 42% in restructuring move; shares down 6% after hours https://seekingalpha.com/news/3346280-catabasis-to-cut-workforce-42-in-restructuring-move-shares-down-6-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3346280-catabasis-to-cut-workforce-42-in-restructuring-move-shares-down-6-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346276\" data-ts=\"1523996822\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LRCX\" target=\"_blank\">LRCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346276-lam-researchminus-2_5-despite-q3-beats-upside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lam Research -2.5% despite Q3 beats, upside guidance</a></h4><ul><li>        Lam Research (NASDAQ:<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a>) shares are&nbsp;<font color='red'>down 2.5%</font>&nbsp;aftermarket following Q3 results that beat EPS and revenue estimates. Upside Q4 guidance has revenue from $2.95B to $3.25B (consensus: $2.94B) with EPS from $4.80 to $5.20 (consensus: $4.65) and non-GAAP gross margin of 46.5% to 48.5%.&nbsp;</li><li>        Key metrics: Shipments, $3.13B (+19% Q/Q); non-GAAP gross margin, 46.8% (-80 bps); operating margin, 30% (-20 bps); cash and equivalents, $6.7B; deferred revenue, $1.1B; deferred profit, $749M.</li><li>               <a href=\"https://seekingalpha.com/pr/17132490-lam-research-corporation-reports-financial-results-quarter-ended-march-25-2018\" target=\"_blank\">Press release </a>&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346251-lam-research-beats-0_43-beats-revenue\" target=\"_blank\">Lam Research beats by $0.43, beats on revenue</a> (April 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346276\" data-linked=\"Lam Research -2.5% despite Q3 beats, upside guidance\" data-tweet=\"$LRCX - Lam Research -2.5% despite Q3 beats, upside guidance https://seekingalpha.com/news/3346276-lam-researchminus-2_5-despite-q3-beats-upside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3346276-lam-researchminus-2_5-despite-q3-beats-upside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>86&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346272\" data-ts=\"1523996712\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UAL\" target=\"_blank\">UAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346272-united-rallies-after-earnings-guidance-satisfy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">United rallies after earnings, guidance satisfy</a></h4><ul> <li>United Continental (NASDAQ:<a href='https://seekingalpha.com/symbol/UAL' title='United Continental Holdings, Inc'>UAL</a>) reports consolidated passenger revenue per available seat mile increased 2.7% in <a href=\"https://seekingalpha.com/pr/17132540-united-airlines-reports-first-quarter-2018-performance\" target=\"_blank\">Q1</a>. Consolidated unit cost per available seat mile was 4.3% higher during the quarter.</li> <li>The company churned up operating revenue of $9.02B to edge past the consensus estimate of analysts, while EPS was also higher than expected after factoring out some special charges. Pre-tax margin was up 20 bps to 2.0% of revenue. Operating margin fell 90 bps to 3.5% of revenue.</li> <li>Looking ahead, United sees FY18 EPS of $7.00 to $8.50 vs. $7.67 consensus, a tightening up of prior guidance.</li> <li>\"We continue to execute our strategy to strengthen and grow our domestic network, drive asset efficiency and productivity, while also continuing our focus on our customers,\" says CEO Oscar Munoz on the quarter and full-year forecast.</li> <li>Shares of UAL are <font color='green'>up 2.61%</font> AH to $69.10.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346265-united-continental-beats-0_01-beats-revenue\" target=\"_blank\">United Continental beats by $0.01, beats on revenue</a> (April 17)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346272\" data-linked=\"United rallies after earnings, guidance satisfy\" data-tweet=\"$UAL - United rallies after earnings, guidance satisfy https://seekingalpha.com/news/3346272-united-rallies-after-earnings-guidance-satisfy?source=tweet\" data-url=\"https://seekingalpha.com/news/3346272-united-rallies-after-earnings-guidance-satisfy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346271\" data-ts=\"1523996655\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISRG\" target=\"_blank\">ISRG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346271-intuitive-surgical-q1-top-line-off-5-non-gaap-earnings-down-6-shares-up-5-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intuitive Surgical Q1 top line off 5%; non-GAAP earnings down 6%; shares up 5% after hours consensus beat</a></h4><ul><li>Intuitive Surgical (NASDAQ:<a href='https://seekingalpha.com/symbol/ISRG' title='Intuitive Surgical, Inc.'>ISRG</a>) <a href=\"https://seekingalpha.com/pr/17132492-intuitive-surgical-announces-first-quarter-earnings\" target=\"_blank\">Q1 results</a> ($M): Total revenue: 847.5 (-5.0%); Instruments &amp; accessories: 460.3 (+0.7%); Systems: 234.5 (-17.6%); Services: 152.7 (+1.5%).</li><li>Net income: 287.6 (+999%); non-GAAP net income: 287.5 (-5.7%); EPS: 2.44 (+971.4%); non-GAAP EPS: 2.44 (-6.2%).</li><li><em>da Vinci </em>system shipments: 185 (+39.1%).</li><li>Consensus view was non-GAAP EPS of $2.09 on revenue of $783.3M.</li><li>Shares are up&nbsp;<font color='green'>5%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346271\" data-linked=\"Intuitive Surgical Q1 top line off 5%; non-GAAP earnings down 6%; shares up 5% after hours consensus beat\" data-tweet=\"$ISRG - Intuitive Surgical Q1 top line off 5%; non-GAAP earnings down 6%; shares up 5% after hours consensus beat https://seekingalpha.com/news/3346271-intuitive-surgical-q1-top-line-off-5-non-gaap-earnings-down-6-shares-up-5-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3346271-intuitive-surgical-q1-top-line-off-5-non-gaap-earnings-down-6-shares-up-5-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346254\" data-ts=\"1523995729\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSX\" target=\"_blank\">CSX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346254-csx-beats-0_12-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CSX beats by $0.12, beats on revenue</a></h4><ul><li>CSX (NYSE:<a href='https://seekingalpha.com/symbol/CSX' title='CSX Corporation'>CSX</a>): Q1 EPS of $0.78 <font color='green'>beats by $0.12</font>.</li><li>Revenue of $2.88B (+0.3% Y/Y) <font color='green'>beats by $50M</font>.</li><li>Shares <font color='green'>+2.86%</font>.</li><li><a href='https://seekingalpha.com/pr/17132478-csx-announces-record-first-quarter-2018-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3346254\" data-linked=\"CSX beats by $0.12, beats on revenue\" data-tweet=\"$CSX - CSX beats by $0.12, beats on revenue https://seekingalpha.com/news/3346254-csx-beats-0_12-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3346254-csx-beats-0_12-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346253\" data-ts=\"1523995717\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISRG\" target=\"_blank\">ISRG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346253-intuitive-surgical-beats-0_35-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intuitive Surgical beats by $0.35, beats on revenue</a></h4><ul><li>Intuitive Surgical (NASDAQ:<a href='https://seekingalpha.com/symbol/ISRG' title='Intuitive Surgical, Inc.'>ISRG</a>): Q1 EPS of $2.44 <font color='green'>beats by $0.35</font>.</li><li>Revenue of $847.5M (+24.7% Y/Y) <font color='green'>beats by $64.22M</font>.</li><li>Shares <font color='green'>+4.26%</font>.</li><li><a href='https://seekingalpha.com/pr/17132492-intuitive-surgical-announces-first-quarter-earnings'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3346253\" data-linked=\"Intuitive Surgical beats by $0.35, beats on revenue\" data-tweet=\"$ISRG - Intuitive Surgical beats by $0.35, beats on revenue https://seekingalpha.com/news/3346253-intuitive-surgical-beats-0_35-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3346253-intuitive-surgical-beats-0_35-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346252\" data-ts=\"1523995670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSX\" target=\"_blank\">CSX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346252-csx-higher-after-earnings-shine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CSX higher after earnings shine</a></h4><ul> <li>CSX (NYSE:<a href='https://seekingalpha.com/symbol/CSX' title='CSX Corporation'>CSX</a>) reports its operating ratio improved to 63.7% in <a href=\"https://seekingalpha.com/pr/17132478-csx-announces-record-first-quarter-2018-financial-results\" target=\"_blank\">Q1</a> from 73.2% a year ago.</li> <li>Revenue was flat during the quarter at $2.88B, while operating income jumped 36% to $1.04B.</li> <li>\"Since implementation of scheduled railroading began in March 2017, CSX has taken significant strides to transform the organization and to make CSX more competitive,\" says CEO James Foote.</li> <li>Management is due to provide guidance on the company's conference call set for 4:30 p.m.</li><li>CSX&nbsp;<font color='green'>+2.35%</font>&nbsp;AH to $57.90.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346252\" data-linked=\"CSX higher after earnings shine\" data-tweet=\"$CSX - CSX higher after earnings shine https://seekingalpha.com/news/3346252-csx-higher-after-earnings-shine?source=tweet\" data-url=\"https://seekingalpha.com/news/3346252-csx-higher-after-earnings-shine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346242\" data-ts=\"1523995076\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APPN\" target=\"_blank\">APPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346242-appianplus-2_1-on-headquarters-expansion-plans\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Appian +2.1% on headquarters expansion plans</a></h4><ul><li>        Appian (NASDAQ:<a href='https://seekingalpha.com/symbol/APPN' title='Appian Corp.'>APPN</a>) will <a href=\"https://www.businesswire.com/news/home/20180417006352/en/Fairfax-County-Based-Appian-Add-600-Jobs-Invest\" target=\"_blank\">invest $28.4M</a> to expand its headquarters in Fairfax County, Virginia.</li><li>               The company will move into the 785K square-foot campus at Valo Park. The project will retain 600 jobs and add 600 new jobs over the next five years.&nbsp;</li><li>               Appian shares are&nbsp;<font color='green'>up 2.1%</font>&nbsp;to $26.80.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3346242\" data-linked=\"Appian +2.1% on headquarters expansion plans\" data-tweet=\"$APPN - Appian +2.1% on headquarters expansion plans https://seekingalpha.com/news/3346242-appianplus-2_1-on-headquarters-expansion-plans?source=tweet\" data-url=\"https://seekingalpha.com/news/3346242-appianplus-2_1-on-headquarters-expansion-plans\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346240\" data-ts=\"1523994218\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTVT\" target=\"_blank\">VTVT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346240-bargain-hunters-jump-vtv-therapeutics-shares-up-71\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bargain hunters jump into vTv Therapeutics, shares up 71%</a></h4><ul><li>Nano cap vTv Therapeutics (<a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics'>VTVT</a> <font color='green'>+70.9%</font>) jumps on a healthy 19x surge in volume as bargain hunters move in. Shares plummeted last week after lead drug azeliragon failed a late-stage study in Alzheimer's.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344522-vtv-therapeutics-azeliragon-flunks-late-stage-alzheimers-study\" target=\"_blank\">vTv Therapeutics' azeliragon flunks late-stage Alzheimer's study</a> (April 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346240\" data-linked=\"Bargain hunters jump into vTv Therapeutics, shares up 71%\" data-tweet=\"$VTVT - Bargain hunters jump into vTv Therapeutics, shares up 71% https://seekingalpha.com/news/3346240-bargain-hunters-jump-vtv-therapeutics-shares-up-71?source=tweet\" data-url=\"https://seekingalpha.com/news/3346240-bargain-hunters-jump-vtv-therapeutics-shares-up-71\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346233\" data-ts=\"1523993057\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFY\" target=\"_blank\">INFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346233-bloomberg-infosys-ceo-will-sacrifice-profit-now-for-market-opportunities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Infosys CEO will sacrifice profit now for market opportunities</a></h4><ul><li>        New Infosys (NASDAQ:<a href='https://seekingalpha.com/symbol/INFY' title='Infosys Limited, Inc.'>INFY</a>) CEO Salil Parekh <a href=\"https://www.bloomberg.com/news/articles/2018-04-17/new-infosys-ceo-says-now-is-time-to-sacrifice-margins-for-growth\" target=\"_blank\">tells Bloomberg</a> the company needs to sacrifice profit margins to invest in advanced tech to gain more market opportunities.</li><li>               Parekh: &ldquo;To build the future of Infosys, we have to make those investments now. If we don&rsquo;t do that now, the real concern is that we won&rsquo;t be relevant to our clients in the future.&rdquo;&nbsp;</li><li>               On Monday, Infosys said it expected operating margins to be 22% to 24%, which was lower on the year.&nbsp;</li><li>               Parekh says Infosys can use its experience and skills to help customers shift to newer tech trends like cloud computing and AI. Doing so could help grow the digital services revenue, which is currently $2.8B but the company sees the potential for $200B.&nbsp;</li><li>               The new CEO is also on watch for potential acquisitions and has asked the company&rsquo;s M&amp;A team to draw up a short list of potential targets that could &ldquo;help accelerate our digital pace.&rdquo; &nbsp;&nbsp;</li><li>               Infosys shares are<font color='red'> down 0.9%</font>&nbsp;to $16.83.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3345494-infosys-minus-2_8-percent-q4-beat-net-profit-drop-acquisition-announcement\" target=\"_blank\">Infosys -2.8% on Q4 beat with net profit drop, acquisition announcement</a> (April 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346233\" data-linked=\"Bloomberg: Infosys CEO will sacrifice profit now for market opportunities\" data-tweet=\"$INFY - Bloomberg: Infosys CEO will sacrifice profit now for market opportunities https://seekingalpha.com/news/3346233-bloomberg-infosys-ceo-will-sacrifice-profit-now-for-market-opportunities?source=tweet\" data-url=\"https://seekingalpha.com/news/3346233-bloomberg-infosys-ceo-will-sacrifice-profit-now-for-market-opportunities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346231\" data-ts=\"1523992330\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DBX\" target=\"_blank\">DBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346231-dropboxplus-2_9-on-analyst-initiations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dropbox +2.9% on analyst initiations</a></h4><ul><li>        Dropbox (NASDAQ:<a href='https://seekingalpha.com/symbol/DBX' title='Dropbox'>DBX</a>) shares are up 2.9% after a number of <a href=\"https://www.marketwatch.com/story/dropbox-stock-gains-as-analysts-start-coverage-with-mostly-buy-ratings-2018-04-17?siteid=rss&amp;rss=1\" target=\"_blank\">analyst initiations</a>.</li><li>               JPMorgan initiates Dropbox at an Overweight rating and a $32 price target.&nbsp;</li><li>               Analyst Mark Murphy says the company&rsquo;s neutral platform gives it an advantage over its peers because Dropbox can play nicely with all the major players. &nbsp;&nbsp;</li><li>               Canaccord Genuity gives Dropbox a Buy rating and a $35 target.&nbsp;</li><li>               Analyst Richard Davis says cloud storage represents a $30B annual market opportunity and that Dropbox has developed a &ldquo;leading model&rdquo; and has attractive financials.&nbsp;</li><li>               Davis notes FCF margins &ldquo;north of 20%,&rdquo; which he thinks can grow to over 30% in time, and gross margins over 70%.&nbsp;</li><li>               More action: Piper Jaffray initiates Dropbox with an Overweight rating and a $40 price target.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3345753-dropbox-target-raised-20-percent-upside\" target=\"_blank\">Dropbox target raised to 20% upside</a> (April 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346231\" data-linked=\"Dropbox +2.9% on analyst initiations\" data-tweet=\"$DBX - Dropbox +2.9% on analyst initiations https://seekingalpha.com/news/3346231-dropboxplus-2_9-on-analyst-initiations?source=tweet\" data-url=\"https://seekingalpha.com/news/3346231-dropboxplus-2_9-on-analyst-initiations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346230\" data-ts=\"1523992313\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTZ\" target=\"_blank\">HTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346230-volatility-picks-up-on-hertz-and-avis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Volatility picks up on Hertz and Avis</a></h4><ul> <li>Hertz Global (<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a> <font color='red'>-7.9%</font>) and Avis Budget Group (<a href='https://seekingalpha.com/symbol/CAR' title='Avis Budget Group, Inc.'>CAR</a> <font color='red'>-4.3%</font>) are sharply lower on the day.</li> <li>The outsized moves are being tied to an elevated level of options trading on the car rental stocks.</li> <li>On a YTD look, shares of Hertz are down 7.4%, while Avis is up 8.0%.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3346230\" data-linked=\"Volatility picks up on Hertz and Avis\" data-tweet=\"$HTZ $HTZ $CAR - Volatility picks up on Hertz and Avis https://seekingalpha.com/news/3346230-volatility-picks-up-on-hertz-and-avis?source=tweet\" data-url=\"https://seekingalpha.com/news/3346230-volatility-picks-up-on-hertz-and-avis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346228\" data-ts=\"1523991624\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DPW\" target=\"_blank\">DPW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346228-technology-top-5-gainers-losers-of-3-00-pm-04-17-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 PM (04/17/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/SMSI' title='Smith Micro Software, Inc.'>SMSI</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/QUIK' title='QuickLogic Corporation'>QUIK</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SEAC' title='SeaChange International, Inc.'>SEAC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/NNDM' title='Nano Dimension Ltd ADR'>NNDM</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/ISNS' title='Image Sensing Systems, Inc.'>ISNS</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/DCAR' title='DropCar, Inc.'>DCAR</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346228\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 PM (04/17/2018)\" data-tweet=\"$DPW $DPW $SMSI - Technology - Top 5 Gainers / Losers as of 3:00 PM (04/17/2018) https://seekingalpha.com/news/3346228-technology-top-5-gainers-losers-of-3-00-pm-04-17-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3346228-technology-top-5-gainers-losers-of-3-00-pm-04-17-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346224\" data-ts=\"1523990205\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346224-amazon-roundup-whole-foods-rewards-end-sci-fi-series-join-content-order\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon roundup: Whole Foods rewards end, sci-fi series could join content order</a></h4><ul><li>        Amazon&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) Whole Foods Market <a href=\"https://www.marketwatch.com/story/whole-foods-to-end-rewards-program-suggesting-it-will-be-folded-into-amazon-prime-2018-04-17\" target=\"_blank\">sent an email</a> to loyalty program members saying the program and digital coupons will end on May 2.</li><li>               Online accounts will also end on that day.&nbsp;</li><li>               The FAQ page for coupons and rewards says to keep looking for &ldquo;additional announcements for Amazon Prime members.&rdquo; The page also says that account benefits won&rsquo;t roll into future programs.&nbsp;</li><li>               New content: <a href=\"http://variety.com/2018/tv/news/william-gibsons-the-peripheral-1202754934/\" target=\"_blank\">Variety reports</a> that Amazon is developing a series based on William Gibson&rsquo;s sci-fi novel <i>The Peripheral</i>.&nbsp;</li><li>               The series is under consideration for a straight-to-series order. Scott B. Smith will write and executive produce while <i>Westworld</i> creators Lisa Joy and Jonathan Nolan will serve as executive producers.&nbsp;</li><li>Amazon shares are&nbsp;<font color='green'>up 3.8%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346181-reuters-supreme-court-uncertain-e-commerce-tax-decision\" target=\"_blank\">Reuters: Supreme Court uncertain on e-commerce tax decision</a> (April 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346224\" data-linked=\"Amazon roundup: Whole Foods rewards end, sci-fi series could join content order\" data-tweet=\"$AMZN - Amazon roundup: Whole Foods rewards end, sci-fi series could join content order https://seekingalpha.com/news/3346224-amazon-roundup-whole-foods-rewards-end-sci-fi-series-join-content-order?source=tweet\" data-url=\"https://seekingalpha.com/news/3346224-amazon-roundup-whole-foods-rewards-end-sci-fi-series-join-content-order\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346223\" data-ts=\"1523990046\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAS\" target=\"_blank\">HAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346223-hasbro-and-mattel-lower-after-toys-r-rescue-thwarted\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hasbro and Mattel lower after Toys &quot;R&quot; rescue thwarted</a></h4><ul>     <li>Hasbro (<a href='https://seekingalpha.com/symbol/HAS' title='Hasbro, Inc.'>HAS</a> <font color='red'>-1.7%</font>) and Mattel (<a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a> <font color='red'>-1.4%</font>) are lower on the day amid <a href=\"https://www.wsj.com/articles/toys-r-us-rules-out-billionaire-bratz-makers-offer-1523986175\" target=\"_blank\">reports</a> that an offer from MGA Entertainment's Isaac Larian for Toys \"R' Us was turned down.</li>     <li>Sources indicate that the Larian offer didn't meet the qualified bid threshold as set by the court-approved auction procedures.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346223\" data-linked=\"Hasbro and Mattel lower after Toys &quot;R&quot; rescue thwarted\" data-tweet=\"$HAS $HAS $MAT - Hasbro and Mattel lower after Toys &quot;R&quot; rescue thwarted https://seekingalpha.com/news/3346223-hasbro-and-mattel-lower-after-toys-r-rescue-thwarted?source=tweet\" data-url=\"https://seekingalpha.com/news/3346223-hasbro-and-mattel-lower-after-toys-r-rescue-thwarted\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346216\" data-ts=\"1523988524\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JONE\" target=\"_blank\">JONE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346216-jones-energy-terminates-ceo-jones-president-mcconnell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jones Energy terminates CEO Jones, President McConnell</a></h4><ul>     <li>Jones Energy (<a href='https://seekingalpha.com/symbol/JONE' title='Jones Energy, Inc.'>OTC:JONE</a> <font color='green'>+14.4%</font>) shoots higher after disclosing CEO Jonny Jones and President Mike McConnell were <a href=\"https://www.sec.gov/Archives/edgar/data/1573166/000110465918024445/a18-11074_28k.htm\" target=\"_blank\">terminated</a> from their positions, effective immediately, although Jones will continue to serve as Chairman and McConnell will remain a board member.</li>     <li>JONE appoints Jeff Tanner as COO and interim CEO; Tanner joined the company in 2014 and currently serves as Executive VP for Geosciences and Business Development.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346216\" data-linked=\"Jones Energy terminates CEO Jones, President McConnell\" data-tweet=\"$JONE - Jones Energy terminates CEO Jones, President McConnell https://seekingalpha.com/news/3346216-jones-energy-terminates-ceo-jones-president-mcconnell?source=tweet\" data-url=\"https://seekingalpha.com/news/3346216-jones-energy-terminates-ceo-jones-president-mcconnell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346213\" data-ts=\"1523988328\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOC\" target=\"_blank\">NOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346213-new-weapons-sales-policy-come-this-week-reuters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New weapons sales policy could come this week - Reuters</a></h4><ul><li>A \"Buy American\" initiative for the weapons industry <a href=\"https://www.reuters.com/article/us-usa-trump-arms-insight/arming-the-world-inside-trumps-buy-american-drive-to-expand-weapons-exports-idUSKBN1HO2PT\" target=\"_blank\">may be unveiled as soon</a> as this week, reports Reuters. Aimed at allowing more countries to buy more and bigger weapons, the plan would cut export rules things like fighter jets, drones, warships, and artillery, and everything in between, according to the story.</li><li>The timing for sales approvals could be trimmed to months from what has previously often taken years.</li><li>&ldquo;This policy seeks to mobilize the full resources of the United States government behind arms transfers that are in the U.S. national and economic security interest,&rdquo; says an administration source.</li><li>Interested parties include: Northrop Grumman (<a href='https://seekingalpha.com/symbol/NOC' title='Northrop Grumman Corporation'>NOC</a> <font color='green'>+0.2%</font>), Lockheed Martin (<a href='https://seekingalpha.com/symbol/LMT' title='Lockheed Martin'>LMT</a> <font color='green'>+0.6%</font>), Raytheon (<a href='https://seekingalpha.com/symbol/RTN' title='Raytheon Company'>RTN</a> <font color='green'>+0.5%</font>), and Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='green'>+1.4%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346213\" data-linked=\"New weapons sales policy could come this week - Reuters\" data-tweet=\"$NOC $NOC $LMT - New weapons sales policy could come this week - Reuters https://seekingalpha.com/news/3346213-new-weapons-sales-policy-come-this-week-reuters?source=tweet\" data-url=\"https://seekingalpha.com/news/3346213-new-weapons-sales-policy-come-this-week-reuters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346212\" data-ts=\"1523988324\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSN\" target=\"_blank\">OSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346212-energy-materials-top-gainers-losers-of-2-05-pm-04-17-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:05 PM (04/17/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/OSN' title='Ossen Innovation Co., Ltd.'>OSN</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/WMLP-OLD' title='Westmoreland Resource Partners, LP'>WMLP-OLD</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/WTI' title='W&T Offshore, Inc.'>WTI</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services'>PES</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/LGCY' title='Legacy Reserves Inc'>LGCY</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TMQ' title='Trilogy Metals Inc.'>TMQ</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/FSI' title='Flexible Solutions International, Inc'>FSI</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346212\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:05 PM (04/17/2018)\" data-tweet=\"$OSN $OSN $WMLP-OLD - Energy/Materials - Top Gainers / Losers as of 2:05 PM (04/17/2018) https://seekingalpha.com/news/3346212-energy-materials-top-gainers-losers-of-2-05-pm-04-17-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3346212-energy-materials-top-gainers-losers-of-2-05-pm-04-17-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346257\" data-ts=\"1523987864\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHK\" target=\"_blank\">CHK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346257-chesapeake-energy-cut-to-sell-citi-lowers-natural-gas-price-forecast\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chesapeake Energy cut to Sell as Citi lowers natural gas price forecast</a></h4><ul><li>Chesapeake Energy (<a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color='red'>-2.3%</font>) is lower after Citigroup <a href=\"https://thefly.com/thestreet/realmoney/index.php/CHKid2713600/CHK-Chesapeake-downgraded-to-Sell-from-Neutral-at-Citi\" target=\"_blank\">downgrades shares to Sell</a> from Neutral with a $2 price target, cut from $5, the result of the firm's reduced price outlook for natural gas.</li><li>Citi lowers its 2018 composite spot natural gas price forecast to $2.75/MMBtu from $3 as well as its 2019 outlook to $2.60/MMBtu from $3.35.</li><li>The firm also downgrades Antero Resources (<a href='https://seekingalpha.com/symbol/AR' title='Antero Resources Corporation'>AR</a> <font color='red'>-1.1%</font>), Cabot Oil and Gas (<a href='https://seekingalpha.com/symbol/COG' title='Cabot Oil & Gas Corporation'>COG</a> <font color='red'>-0.5%</font>), Range Resources (<a href='https://seekingalpha.com/symbol/RRC' title='Range Resources Corporation'>RRC</a> <font color='red'>-2.4%</font>) and Southwestern Energy (<a href='https://seekingalpha.com/symbol/SWN' title='Southwestern Energy Co.'>SWN</a> <font color='green'>+0.8%</font>) to Neutral from Buy.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346257\" data-linked=\"Chesapeake Energy cut to Sell as Citi lowers natural gas price forecast\" data-tweet=\"$CHK $CHK $AR - Chesapeake Energy cut to Sell as Citi lowers natural gas price forecast https://seekingalpha.com/news/3346257-chesapeake-energy-cut-to-sell-citi-lowers-natural-gas-price-forecast?source=tweet\" data-url=\"https://seekingalpha.com/news/3346257-chesapeake-energy-cut-to-sell-citi-lowers-natural-gas-price-forecast\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>100&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346207\" data-ts=\"1523987021\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIGL\" target=\"_blank\">RIGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346207-trading-in-rigel-halted-ahead-of-expected-fda-ok-for-tavalisse-for-immune-thrombocytopenia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trading in Rigel halted ahead of expected FDA OK for Tavalisse for immune thrombocytopenia; shares up 10%</a></h4><ul><li>Nasdaq has suspended trading in Rigel Pharmaceuticals (<a href='https://seekingalpha.com/symbol/RIGL' title='Rigel Pharmaceuticals, Inc.'>RIGL</a> <font color='green'>+10.2%</font>) based on abnormal volatility. Today is the FDA's action date for its review of the company's marketing application seeking approval for Tavalisse (fostamatinib) for the treatment of chronic or persistent immune thrombocytopenia (low blood platelets).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3298670-ad-com-review-rigels-marketing-application-thrombocytopenia-med-fostamatinib-shares-ahead-14\" target=\"_blank\">No Ad Com review for Rigel's marketing application for thrombocytopenia med fostamatinib; shares ahead 14% premarket</a> (Oct. 2, 2017)</li><li><strong>Update</strong>: The company <a href=\"http://ir.ultragenyx.com/news-releases/news-release-details/ultragenyx-and-kyowa-kirin-announce-fda-approval-crysvitar\" target=\"_blank\">reported </a>that it has received the FDA nod.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346207\" data-linked=\"Trading in Rigel halted ahead of expected FDA OK for Tavalisse for immune thrombocytopenia; shares up 10%\" data-tweet=\"$RIGL - Trading in Rigel halted ahead of expected FDA OK for Tavalisse for immune thrombocytopenia; shares up 10% https://seekingalpha.com/news/3346207-trading-in-rigel-halted-ahead-of-expected-fda-ok-for-tavalisse-for-immune-thrombocytopenia?source=tweet\" data-url=\"https://seekingalpha.com/news/3346207-trading-in-rigel-halted-ahead-of-expected-fda-ok-for-tavalisse-for-immune-thrombocytopenia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346206\" data-ts=\"1523986979\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DIS\" target=\"_blank\">DIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346206-fivethirtyeight-leaves-espn-to-settle-abc-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FiveThirtyEight leaves ESPN to settle at ABC News</a></h4><ul>   <li>Data-analysis brand FiveThirtyEight is leaving ESPN but staying under the Disney (<a href=\"http://seekingalpha.com/symbol/DIS\" target=\"_blank\">DIS</a> <font color='green'>+1.9%</font>) umbrella, <a href=\"https://twitter.com/NateSilver538/status/986296939909189632\" target=\"_blank\">resettling with ABC News</a>.</li>    <li>The news network fell into a <a href=\"https://seekingalpha.com/news/3335790-fivethirtyeight-suitors-narrow-atlantic-athletic-abc-news\" target=\"_blank\">final few suitors in early March</a>, along with The Atlantic and The Athletic.</li>    <li>While aligning closely with ABC News will provide political strength going into the midterm elections, founder Nate Silver says FiveThirtyEight \"will also cover sports just as before; we'll continue to work with ESPN to showcase our sports coverage.\"</li><li>FiveThirtyEight became part of ESPN&nbsp;five years ago.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346206\" data-linked=\"FiveThirtyEight leaves ESPN to settle at ABC News\" data-tweet=\"$DIS - FiveThirtyEight leaves ESPN to settle at ABC News https://seekingalpha.com/news/3346206-fivethirtyeight-leaves-espn-to-settle-abc-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3346206-fivethirtyeight-leaves-espn-to-settle-abc-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346205\" data-ts=\"1523986720\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346205-facebook-reopens-review-of-instant-games-and-messenger-apps\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook reopens review of Instant Games and Messenger apps</a></h4><ul>    <li>Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color='green'>+2.2%</font>) has reopened a review of Instant Games and apps on Messenger, Bloomberg says, a process it's \"still refining as it works to ensure platform integrity.</li>    <li>The review of the games in its queue should take several weeks, after which time it can look at newly submitted games.</li>    <li>It's reopening the review this week for developers that support a limited number of Facebook Pages.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346205\" data-linked=\"Facebook reopens review of Instant Games and Messenger apps\" data-tweet=\"$FB - Facebook reopens review of Instant Games and Messenger apps https://seekingalpha.com/news/3346205-facebook-reopens-review-of-instant-games-and-messenger-apps?source=tweet\" data-url=\"https://seekingalpha.com/news/3346205-facebook-reopens-review-of-instant-games-and-messenger-apps\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346204\" data-ts=\"1523986425\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RARE\" target=\"_blank\">RARE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346204-fda-oks-ultragenyxs-crysvita-for-xlh-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Ultragenyx&#39;s Crysvita for XLH; shares up 4%</a></h4><ul><li>Ultragenyx (<a href='https://seekingalpha.com/symbol/RARE' title='Ultragenyx Pharmaceutical Inc.'>RARE</a> <font color='green'>+4.1%</font>) is up on average volume on the heels of the U.S. <a href=\"https://in.reuters.com/article/us-ultragenyx-fda/fda-approves-ultragenyxs-treatment-for-rare-type-of-rickets-idINKBN1HO2NW?feedType=RSS&amp;feedName=health&amp;utm_source=Twitter&amp;utm_medium=Social&amp;utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29\" target=\"_blank\">approval </a>for Crysvita (burosumab) for the treatment of patients with a rare musculoskeletal disorder called X-linked hypophosphatemia &#40;XLH&#41;.</li><li>Burosumab is a fully human recombinant monoclonla IgG1 antibody that binds to (inhibits) the phosphaturic hormone fibroblast growth factor 23 (FGF23), a hormone that reduces blood levels of phosphorus and active vitamin D by regulating phosphate excretion and active vitamin D production by the kidney.</li><li>The company will also receive a Priority Review Voucher which can be used for accelerated review for a future product or sold to a third party.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3306629-ad-com-review-planned-ultragenyx-bla-burosumab-xlh-action-date-april-2018-shares-3-percent\" target=\"_blank\">No Ad Com review planned for Ultragenyx BLA for burosumab for XLH, action date April 2018; shares up 3%</a> (Nov. 1, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346204\" data-linked=\"FDA OKs Ultragenyx&#39;s Crysvita for XLH; shares up 4%\" data-tweet=\"$RARE - FDA OKs Ultragenyx&#39;s Crysvita for XLH; shares up 4% https://seekingalpha.com/news/3346204-fda-oks-ultragenyxs-crysvita-for-xlh-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3346204-fda-oks-ultragenyxs-crysvita-for-xlh-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346203\" data-ts=\"1523985689\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNET\" target=\"_blank\">CNET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346203-chinanet-onlineplus-44_5-after-doubling-search-engine-revenues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ChinaNet Online +44.5% after doubling search engine revenues</a></h4><ul>   <li>ChinaNet Online (NASDAQ:<a href='https://seekingalpha.com/symbol/CNET' title='ChinaNet Online Holdings, Inc.'>CNET</a>) is <font color='green'>up 44.5%</font> in Nasdaq trading after posting <a href=\"https://seekingalpha.com/news/3346053-chinanet-online-reports-q4-results\" target=\"_blank\">Q4 earnings</a> where revenues got a boost from a migration toward search engine advertising.</li>    <li>Overall revenues grew 64% to $15.3M. Search engine marketing and data service revenue, though, rose 121% to $13.1M.</li>    <li>Operating expenses fell to 40.7% of total revenue vs. $42.9% a year ago.</li>    <li>Operating loss was $6M vs. the prior year's loss of $2.4M; net loss came to $6.2M, widening from a loss of $2.3M a year earlier.</li>    <li>\"Realizing that our small-to-medium enterprise or SME customers are struggling as the Chinese economy slows down, we have actively migrated our business focus towards servicing larger customers and providing search-engine advertising solutions,\" says CEO Handong Cheng.</li>    <li>Cash and equivalents came to $3M.</li>    <li><a href=\"https://seekingalpha.com/pr/17131321-chinanet-online-holdings-reports-fourth-quarter-full-year-2017-unaudited-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3346203\" data-linked=\"ChinaNet Online +44.5% after doubling search engine revenues\" data-tweet=\"$CNET - ChinaNet Online +44.5% after doubling search engine revenues https://seekingalpha.com/news/3346203-chinanet-onlineplus-44_5-after-doubling-search-engine-revenues?source=tweet\" data-url=\"https://seekingalpha.com/news/3346203-chinanet-onlineplus-44_5-after-doubling-search-engine-revenues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346198\" data-ts=\"1523984829\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PKBK\" target=\"_blank\">PKBK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346198-parke-bancorp-announces-stock-split-and-increase-regular-dividend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Parke Bancorp announces stock split and increase its regular dividend</a></h4><ul>     <li>Parke Bancorp (<a href='https://seekingalpha.com/symbol/PKBK' title='Parke Bancorp, Inc.'>PKBK</a> <font color='green'>+2.9%</font>) has declared an 11 for 10 stock split, to effectuate a 10% stock dividend.</li>     <li>Payable May 18; for shareholders of record May 5.</li>     <li>In addition, quarterly cash dividend will be increased from $0.12 to $0.14, effective with the July dividend payment.</li><li><a href=\"https://seekingalpha.com/pr/17131937-parke-bancorp-inc-announces-stock-split-increase-quarterly-cash-dividend\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3346198\" data-linked=\"Parke Bancorp announces stock split and increase its regular dividend\" data-tweet=\"$PKBK - Parke Bancorp announces stock split and increase its regular dividend https://seekingalpha.com/news/3346198-parke-bancorp-announces-stock-split-and-increase-regular-dividend?source=tweet\" data-url=\"https://seekingalpha.com/news/3346198-parke-bancorp-announces-stock-split-and-increase-regular-dividend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346197\" data-ts=\"1523984435\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIFS\" target=\"_blank\">CIFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346197-financials-top-gainers-losers-of-1-00-pm-04-17-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM (04/17/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/AIHS' title='Senmiao Technology'>AIHS</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/QIWI' title='QIWI plc'>QIWI</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CURO' title='CURO Group Holdings Corp.'>CURO</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NHLD' title='National Holdings Corp.'>NHLD</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/LADR' title='Ladder Capital Corp'>LADR</a> <font color='red'>-5%.</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3346197\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM (04/17/2018)\" data-tweet=\"$CIFS $CIFS $AIHS - Financials - Top Gainers / Losers as of 1:00 PM (04/17/2018) https://seekingalpha.com/news/3346197-financials-top-gainers-losers-of-1-00-pm-04-17-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3346197-financials-top-gainers-losers-of-1-00-pm-04-17-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346196\" data-ts=\"1523984318\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346196-kudlow-talks-russian-sanctions-russia-etf-dips-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kudlow talks Russian sanctions; Russia ETF dips more than 1%</a></h4><ul><li>Speaking to reporters ahead of meetings between the president and the Japanese prime minister, White House economic advisor Larry Kudlow says more Russian sanctions are under consideration.</li><li>Russia ETFs had rallied yesterday afternoon <a href=\"https://seekingalpha.com/news/3345915-russia-sanctions-halted-president-wapo\" target=\"_blank\">on a <em>Washington Post </em>story</a> saying there would be no additional sanctions. They're back in retreat now. <a href='https://seekingalpha.com/symbol/RSX' title='VanEck Vectors Russia ETF'>RSX</a>&nbsp;<font color='red'>-1.25%</font></li><li>ETFs: <a href='https://seekingalpha.com/symbol/RSX' title='VanEck Vectors Russia ETF'>RSX</a>, <a href='https://seekingalpha.com/symbol/RUSL' title='Direxion Daily Russia Bull 3x Shares ETF'>RUSL</a>, <a href='https://seekingalpha.com/symbol/RUSS' title='Direxion Daily Russia Bear 3x Shares ETF'>RUSS</a>, <a href='https://seekingalpha.com/symbol/ERUS' title='iShares MSCI Russia Capped ETF'>ERUS</a>, <a href='https://seekingalpha.com/symbol/RSXJ' title='VanEck Vectors Russia Small-Cap ETF'>RSXJ</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3346196\" data-linked=\"Kudlow talks Russian sanctions; Russia ETF dips more than 1%\" data-tweet=\"$RSX $RUSL $RUSS - Kudlow talks Russian sanctions; Russia ETF dips more than 1% https://seekingalpha.com/news/3346196-kudlow-talks-russian-sanctions-russia-etf-dips-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3346196-kudlow-talks-russian-sanctions-russia-etf-dips-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346195\" data-ts=\"1523984299\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSV\" target=\"_blank\">GSV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346195-gold-standard-ventures-rises-on-positive-pinion-infill-drilling-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold Standard Ventures rises on positive Pinion infill drilling results</a></h4><ul>     <li>Gold Standard Ventures (<a href='https://seekingalpha.com/symbol/GSV' title='Gold Standard Ventures'>GSV</a> <font color='green'>+1.2%</font>) is higher after reporting <a href=\"https://seekingalpha.com/pr/17131196-gold-standard-reports-positive-infill-drilling-results-pinion-oxide-gold-deposit-carlin-trend\" target=\"_blank\">positive infill drilling results</a> at the Pinion oxide gold deposit at its Railroad-Pinion project in Nevada's Carlin Trend.</li>     <li>GSV says two reverse circulation and two core rigs have completed 8,126m of infill drilling in 87 holes.</li>     <li>GSv expects Infill and development work this year at Dark Star and Pinion to account for ~40,800m of drilling in 296 holes while exploration should add another 34,000m of drilling in 85 holes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346195\" data-linked=\"Gold Standard Ventures rises on positive Pinion infill drilling results\" data-tweet=\"$GSV - Gold Standard Ventures rises on positive Pinion infill drilling results https://seekingalpha.com/news/3346195-gold-standard-ventures-rises-on-positive-pinion-infill-drilling-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3346195-gold-standard-ventures-rises-on-positive-pinion-infill-drilling-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346193\" data-ts=\"1523984015\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EIGR\" target=\"_blank\">EIGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346193-eigers-lonafarnib-significantly-reduced-hdv-in-patients-low-viral-loads-in-mid-stage-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eiger&#39;s lonafarnib significantly reduced HDV in patients with low viral loads in mid-stage study; shares up 2%</a></h4><ul><li>Eiger BioPharmaceuticals (<a href='https://seekingalpha.com/symbol/EIGR' title='Eiger BioPharmaceuticals, Inc.'>EIGR</a> <font color='green'>+1.8%</font>) says a <a href=\"https://seekingalpha.com/pr/17132085-eiger-announces-sub-analysis-phase-2-results-demonstrating-high-response-rates-oral\" target=\"_blank\">sub-analysis</a> of its Phase 2 LOWR-2 study assessing lonafarnib + ritonavir in patients with hepatitis D virus &#40;HDV&#41; infection demonstrated high response rates in those with low baseline viral loads. The data were presented at The International Liver Congress in Paris.</li><li>After 24 weeks of treatment, 100% of patients with baseline viral loads no greater than 4 log experienced reductions in viral loads to below the limit of quantitation.</li><li>In patients with high baseline viral levels (&gt;4 log), 50% experienced reductions below the limit of quantitation and 88% achieved at least a 2 log (100x)&nbsp;decline at week 24.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3340702-fda-signs-single-registration-trial-eiger-bios-lonafarnib-hdv-shares-3-percent-premarket\" target=\"_blank\">FDA signs off on single registration trial for Eiger Bio's lonafarnib in HDV; shares up 3% premarket</a> (March 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346193\" data-linked=\"Eiger&#39;s lonafarnib significantly reduced HDV in patients with low viral loads in mid-stage study; shares up 2%\" data-tweet=\"$EIGR - Eiger&#39;s lonafarnib significantly reduced HDV in patients with low viral loads in mid-stage study; shares up 2% https://seekingalpha.com/news/3346193-eigers-lonafarnib-significantly-reduced-hdv-in-patients-low-viral-loads-in-mid-stage-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3346193-eigers-lonafarnib-significantly-reduced-hdv-in-patients-low-viral-loads-in-mid-stage-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346189\" data-ts=\"1523983405\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346189-geplus-3_5-on-reported-interest-in-jenbacher-unit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE +3.5% on reported interest in Jenbacher unit</a></h4><ul>     <li>General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='green'>+3.5%</font>) is sharply higher following reports that Cummins (<a href='https://seekingalpha.com/symbol/CMI' title='Cummins Inc.'>CMI</a> <font color='green'>+1%</font>) may be a <a href=\"https://www.barrons.com/articles/ge-rises-on-potential-deal-for-jenbacher-unit-1523982069\" target=\"_blank\">potential suitor for GE's Jenbacher unit</a>.</li>     <li>CMI, as well as CVC Capital Partners, EQT Partners and <a href='https://seekingalpha.com/symbol/KKR' title='KKR'>KKR</a> reportedly are considering a bid that values the Austrian engine maker at more than $3B.</li>     <li>GE is working with Citigroup and Credit Suisse on the sale, which is only in its early stages, <a href=\"https://www.bloomberg.com/news/articles/2018-04-17/ge-s-jenbacher-is-said-to-attract-interest-from-cummins-cvc\" target=\"_blank\">Bloomberg reports</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346189\" data-linked=\"GE +3.5% on reported interest in Jenbacher unit\" data-tweet=\"$GE $GE $CMI - GE +3.5% on reported interest in Jenbacher unit https://seekingalpha.com/news/3346189-geplus-3_5-on-reported-interest-in-jenbacher-unit?source=tweet\" data-url=\"https://seekingalpha.com/news/3346189-geplus-3_5-on-reported-interest-in-jenbacher-unit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>86&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346188\" data-ts=\"1523983254\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNET\" target=\"_blank\">CNET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346188-midday-gainers-losers-04-17-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (04/17/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/CNET' title='ChinaNet Online Holdings, Inc.'>CNET</a> <font color='green'>+42%</font>. <a href='https://seekingalpha.com/symbol/WMLP-OLD' title='Westmoreland Resource Partners, LP'>WMLP-OLD</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/CLXT' title='Calyxt, Inc.'>CLXT</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/IIN' title='IntriCon Corporation'>IIN</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/NVLN' title='Novelion Therapeutics, Inc.'>NVLN</a> <font color='green'>+15%</font>. IFON <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/CHEK' title='Check-Cap Ltd.'>CHEK</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/GTHX' title='G1 Therapeutics'>GTHX</a> <font color='green'>+14%</font>.</li><li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/APLS' title='Apellis Pharmaceuticals, Inc.'>APLS</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/NVMM' title='NOVUME SOLUTIONS INC'>NVMM</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/BLCM' title='Bellicum Pharmaceuticals'>BLCM</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/SEAC' title='SeaChange International, Inc.'>SEAC</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/TMQ' title='Trilogy Metals Inc.'>TMQ</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/GPRO' title='GoPro'>GPRO</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/NNDM' title='Nano Dimension Ltd ADR'>NNDM</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='red'>-7%</font>. SHLD <font color='red'>-6%</font>.</li> &nbsp; </ul><div class=\"tiny-share-widget\" data-id=\"3346188\" data-linked=\"Midday Gainers / Losers (04/17/2018)\" data-tweet=\"$CNET $CNET $WMLP-OLD - Midday Gainers / Losers (04/17/2018) https://seekingalpha.com/news/3346188-midday-gainers-losers-04-17-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3346188-midday-gainers-losers-04-17-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346173\" data-ts=\"1523983008\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCTCF\" target=\"_blank\">JCTCF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346173-jewett-cameron-up-2-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jewett-Cameron up 2% post Q2 results</a></h4><ul><li>Jewett-Cameron (<a href='https://seekingalpha.com/symbol/JCTCF' title='Jewett-Cameron Trading Company'>JCTCF</a> <font color='green'>+2.4%</font>) <a href=\"https://seekingalpha.com/filing/3977465\" target=\"_blank\">reports Q2</a>&nbsp;revenue of $13.34M (+40.4% Y/Y) of which Greenwood were $0.85M (+14.9% Y/Y); JCC $11.4M (+59% Y/Y); JCSC $0.92M (-20.7% Y/Y)&nbsp;&amp; MSI $0.22M (-48% Y/Y).</li><li>Gross margin increased&nbsp;<font color='green'>510 bps</font>&nbsp;to 19.79% Y/Y whereas, operating margin was down&nbsp;<font color='red'>50 bps</font>&nbsp;to 5.39% Y/Y.</li><li>EPS of $0.23 (+64.3% Y/Y); cash balance of $2.79M &amp;&nbsp;working capital of $17.5M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3345954-jewett-cameron-trading-company-reports-q2-results\" target=\"_blank\">Jewett-Cameron Trading Company reports Q2 results</a> (April 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346173\" data-linked=\"Jewett-Cameron up 2% post Q2 results\" data-tweet=\"$JCTCF - Jewett-Cameron up 2% post Q2 results https://seekingalpha.com/news/3346173-jewett-cameron-up-2-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3346173-jewett-cameron-up-2-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346187\" data-ts=\"1523982927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RYAM\" target=\"_blank\">RYAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346187-rayonier-advanced-gets-conference-mention-shares-up-3_3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rayonier Advanced gets conference mention; shares up 3.3%</a></h4><ul><li>Presenting at the 13D conference, Marcato's Mick McGuire says he's an even bigger fan of Rayonier Advanced Materials (<a href='https://seekingalpha.com/symbol/RYAM' title='Rayonier Advanced Materials'>RYAM</a> <font color='green'>+3.3%</font>) after its purchase of Tembec.</li><li>RYAM deserves a higher multiple, he argues, as the deal significantly diversifies its product mix. Synergies represent more than 25% of EBITDA, and he hopes non-core Tembec operations to be sold.</li><li>Marcato sees RYAM rising from anywhere to $34-$61 from the current $21.93.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3346187\" data-linked=\"Rayonier Advanced gets conference mention; shares up 3.3%\" data-tweet=\"$RYAM - Rayonier Advanced gets conference mention; shares up 3.3% https://seekingalpha.com/news/3346187-rayonier-advanced-gets-conference-mention-shares-up-3_3?source=tweet\" data-url=\"https://seekingalpha.com/news/3346187-rayonier-advanced-gets-conference-mention-shares-up-3_3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346185\" data-ts=\"1523982162\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOV\" target=\"_blank\">NOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346185-national-oilwell-varco-down-nearly-10-in-two-days-after-q1-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">National Oilwell Varco down nearly 10% in two days after Q1 warning</a></h4><ul>     <li>National Oilwell Varco (<a href='https://seekingalpha.com/symbol/NOV' title='National Oilwell Varco, Inc.'>NOV</a> <font color='red'>-2.6%</font>) extends its losses a day after <a href=\"https://seekingalpha.com/news/3345733-national-oilwell-varco-expects-q1-revenue-miss\" target=\"_blank\">warning of lower than expected Q1 revenues</a>, citing weaker shipments of subsea production equipment and reduced progress on new offshore rig construction.</li>     <li>B. Riley FBR <a href=\"https://www.streetinsider.com/Analyst+PT+Change/B.RileyFBR+Downgrades+National-Oilwell+Varco+%28NOV%29+to+Neutral%2C+OFS+order+turbulence+as+valuation+reaches+cruising+altitude/14060683.html\" target=\"_blank\">downgrades</a> NOV to Neutral from Buy and lowers its price target to $40 from $42 on heightened risk of a more volatile, if not sustained slower, rate  of newbuild-related orders by oilfield service contractors, especially pressure pumpers.</li><li>For large-cap exposure, B. Riley FBR recommends a rotation of funds from NOV to its new large-cap top pick Schlumberger (<a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a> <font color='green'>+0.2%</font>), which the firm likes due to its hybrid revenue splits for global onshore/offshore oilfield services of 60%/40% and its unique strengths in the international onshore and global deepwater markets.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346185\" data-linked=\"National Oilwell Varco down nearly 10% in two days after Q1 warning\" data-tweet=\"$NOV $NOV $SLB - National Oilwell Varco down nearly 10% in two days after Q1 warning https://seekingalpha.com/news/3346185-national-oilwell-varco-down-nearly-10-in-two-days-after-q1-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3346185-national-oilwell-varco-down-nearly-10-in-two-days-after-q1-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346184\" data-ts=\"1523982150\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346184-big-day-for-chipotle-baird-remains-fan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big day for Chipotle; Baird remains a fan</a></h4><ul><li>A wide range of indicators point to Chipotle (<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a> <font color='green'>+3.2%</font>) as being able to hit its Q1 comparable sales growth estimate of 1.5%, says analyst David Tarantino. And there's potential for better performance in H2.</li><li>Those hoping for detailed plans from new COE Brian Niccol might be disappointed, but Tarantino is prepping some at least a general framework.</li><li>He rates CMG Outperform with a $400 price target, suggesting almost&nbsp;<font color='green'>20% upside</font>.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3346184\" data-linked=\"Big day for Chipotle; Baird remains a fan\" data-tweet=\"$CMG - Big day for Chipotle; Baird remains a fan https://seekingalpha.com/news/3346184-big-day-for-chipotle-baird-remains-fan?source=tweet\" data-url=\"https://seekingalpha.com/news/3346184-big-day-for-chipotle-baird-remains-fan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346181\" data-ts=\"1523981339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/W\" target=\"_blank\">W</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346181-reuters-supreme-court-uncertain-on-e-commerce-tax-decision\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Supreme Court uncertain on e-commerce tax decision</a></h4><ul><li>        U.S. Supreme Court justices <a href=\"https://www.reuters.com/article/us-usa-court-taxes/supreme-court-struggles-with-e-commerce-sales-tax-case-idUSKBN1HO0I0\" target=\"_blank\">appear undecided</a> on whether states should force out-of-state e-commerce companies to collect sales taxes.</li><li>               The case in question relates to South Dakota&rsquo;s desire to overturn a 1992 Supreme Court precedent saying states can&rsquo;t require retailers to collect state sales taxes if the business isn&rsquo;t physically present in the state.&nbsp;</li><li>               Reuters says several justices would prefer for Congress to pass a law that settles the issue on a national basis.&nbsp;</li><li>               South Dakota is appealing a lower court ruling that favored Wayfair (<a href='https://seekingalpha.com/symbol/W' title='Wayfair'>W</a> <font color='green'>+5.7%</font>), Overstock.com (<a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a> <font color='green'>+1.8%</font>), and Newegg. The state passed its own law in 2016 that requires online retailers to collect taxes if total sales cross $100K or 200 separate transactions.&nbsp;</li><li>               President Donald Trump recently went on several Twitter rants about Amazon&rsquo;s (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color='green'>+2.7%</font>) failure to collect state sales taxes and not paying fair rates to the postal service.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3343695-trump-economic-adviser-comments-amazon-level-playing-field\" target=\"_blank\">Trump economic adviser comments on Amazon and \"level playing field\"</a> (April 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346181\" data-linked=\"Reuters: Supreme Court uncertain on e-commerce tax decision\" data-tweet=\"$W $W $OSTK - Reuters: Supreme Court uncertain on e-commerce tax decision https://seekingalpha.com/news/3346181-reuters-supreme-court-uncertain-on-e-commerce-tax-decision?source=tweet\" data-url=\"https://seekingalpha.com/news/3346181-reuters-supreme-court-uncertain-on-e-commerce-tax-decision\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346177\" data-ts=\"1523980867\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLXT\" target=\"_blank\">CLXT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346177-consumer-top-gainers-losers-of-12-00-pm-04-17-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 PM (04/17/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CLXT' title='Calyxt, Inc.'>CLXT</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/KBSF' title='KBS Fashion Group Limited'>KBSF</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/VUZI' title='Vuzix Corp'>VUZI</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/REV' title='Revlon, Inc.'>REV</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GPRO' title='GoPro'>GPRO</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346177\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 PM (04/17/2018)\" data-tweet=\"$CLXT $CLXT $FTFT - Consumer - Top Gainers / Losers as of 12:00 PM (04/17/2018) https://seekingalpha.com/news/3346177-consumer-top-gainers-losers-of-12-00-pm-04-17-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3346177-consumer-top-gainers-losers-of-12-00-pm-04-17-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346150\" data-ts=\"1523980383\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WLMS\" target=\"_blank\">WLMS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346150-global-power-equipment-up-3-on-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global Power Equipment up 3% on Q4 results</a></h4><ul><li>Global Power Equipment (GLPW <font color='green'>+3%</font>) reported Q4 revenue decrease of 25% Y/Y to $44.34M, company sold its Electrical solutions segment.</li><li>Q4 Margins: Gross&nbsp;<font color='green'>improved by 190 bps</font>&nbsp;to 18%, operating&nbsp;<font color='red'>declined by 135 bps&nbsp;</font>to 1.94% and Adjusted EBITDA&nbsp;<font color='red'>declined by 136 bps</font>&nbsp;to 7%.</li><li>Backlog was at $137.7M as of 31 December 2017.</li><li>Q1 2018 Outlook: Backlog ~$150.1M</li><li>&ldquo;The outcome of 2017 was disappointing. Our operating performance was below expectations and the process to evaluate strategic alternatives for our Electrical Solutions (Koontz-Wagner) business has not progressed as quickly as we planned. Additionally, our liquidity position, while somewhat improved recently, continues to constrain our business and, to further complicate matters, closing on a new revolving loan facility in a timely manner has proven to be a challenge&rdquo;, commented Tracy Pagliara, President and CEO.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3345953-global-power-equipment-reports-q4-results\" target=\"_blank\">Global Power Equipment reports Q4 results</a> (April 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346150\" data-linked=\"Global Power Equipment up 3% on Q4 results\" data-tweet=\"$WLMS - Global Power Equipment up 3% on Q4 results https://seekingalpha.com/news/3346150-global-power-equipment-up-3-on-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3346150-global-power-equipment-up-3-on-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346164\" data-ts=\"1523980059\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DSNY\" target=\"_blank\">DSNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346164-destiny-media-scales-26-on-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Destiny Media scales 26% on Q2 results</a></h4><ul><li>Destiny Media Technologies (<a href='https://seekingalpha.com/symbol/DSNY' title='Destiny Media Technologies, Inc.'>OTCQB:DSNY</a> <font color='green'>+26.2%</font>) reported Q2 revenue growth of 4.2% Y/Y to $0.82M due to favorable exchange rates and growth in US independent record labels.</li><li>Q2 operating margin&nbsp;<font color='green'>recovered by 1,727 bps</font>&nbsp;to 8%.</li><li>Q2 Expenses: G&amp;A -27% Y/Y to $0.16M, Sales &amp; marketing -4% Y/Y to $0.26M and R&amp;D -12% Y/Y to $0.30M.&ldquo;</li><li>We've eliminated unproductive &ndash; largely eliminated unproductive spending. We're close to launching v8 of Play MPE. We're improving and possibly adding to our business development team. And when the time is right, we will be making changes to our IR approach&rdquo;, said Fred Vandenberg, CEO.</li><li>Previously:&nbsp;<a href=\"https://seekingalpha.com/news/3345931-destiny-media-technologies-eps-line-beats-revenue\" target=\"_blank\">Destiny Media Technologies EPS in-line, beats on revenue</a>&nbsp;(April 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346164\" data-linked=\"Destiny Media scales 26% on Q2 results\" data-tweet=\"$DSNY - Destiny Media scales 26% on Q2 results https://seekingalpha.com/news/3346164-destiny-media-scales-26-on-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3346164-destiny-media-scales-26-on-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346171\" data-ts=\"1523979832\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346171-supreme-court-dismisses-microsoft-doj-privacy-case\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Supreme Court dismisses Microsoft, DoJ privacy case</a></h4><ul><li>           The U.S. Supreme Court says the privacy fight it was considering between the Justice Department and Microsoft (<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a> <font color='green'>+2.2%</font>) <a href=\"https://www.reuters.com/article/us-usa-court-microsoft/u-s-top-court-rules-that-microsoft-email-privacy-dispute-is-moot-idUSKBN1HO23S?feedType=RSS&amp;feedName=technologyNews&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FtechnologyNews+%28Reuters+Technology+News%29\" target=\"_blank\">is now moot</a> and dismisses the case. </li><li> The case related to whether prosecutors can force tech companies to hand over data that&rsquo;s stored overseas. </li><li>           Both parties had come forward in support of dropping the case due to the recently passed CLOUD Act, which now governs the matter. The DoJ obtained a new warrant under the act.  </li><li> Microsoft shares are&nbsp;<font color='green'>up 2.2%</font>&nbsp;to $96.23.&nbsp;&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3343499-microsoft-backs-doj-asking-supreme-court-drop-case\" target=\"_blank\">Microsoft backs DoJ in asking Supreme Court to drop case</a> (April 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346171\" data-linked=\"Supreme Court dismisses Microsoft, DoJ privacy case\" data-tweet=\"$MSFT - Supreme Court dismisses Microsoft, DoJ privacy case https://seekingalpha.com/news/3346171-supreme-court-dismisses-microsoft-doj-privacy-case?source=tweet\" data-url=\"https://seekingalpha.com/news/3346171-supreme-court-dismisses-microsoft-doj-privacy-case\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346141\" data-ts=\"1523979789\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LAKE\" target=\"_blank\">LAKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346141-lakeland-industries-up-2-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lakeland Industries up 2% post Q4 results</a></h4><ul><li>Lakeland Industries (<a href='https://seekingalpha.com/symbol/LAKE' title='Lakeland Industries, Inc.'>LAKE</a> <font color='green'>+1.5%</font>)&nbsp;<a href=\"https://seekingalpha.com/filing/3977315\" target=\"_blank\">reports Q4 results</a>: Net Sales: $25.16M (+23.9% Y/Y).</li><li>Gross margin was up&nbsp;<font color='green'>120 bps</font>&nbsp;to 39.4% Y/Y whereas, operating margin was down&nbsp;<font color='red'>450 bps</font>&nbsp;to&nbsp;4.9% Y/Y due to hiring of new sales associates, developing new higher margin products and further rolling out Amazon distribution platform in the US.</li><li>Adjusted EBITDA of $2.23M (-8.3% Y/Y);&nbsp;GAAP net loss of $4.9M (-644.4 Y/Y%) &amp; EPS of -$0.64 (-592.3% Y/Y) which included one-time items &amp; non-cash expenses.</li><li>Cash balance: $15.8M (51.9% Y/Y); total debt reduced by 71% Y/Y to $1.7M &amp; Stockholders&rsquo; equity increased by 15.8% Y/Y to $82.8M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3345943-lakeland-industries-eps-0_64\" target=\"_blank\">Lakeland Industries EPS of -$0.64</a> (April 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346141\" data-linked=\"Lakeland Industries up 2% post Q4 results\" data-tweet=\"$LAKE - Lakeland Industries up 2% post Q4 results https://seekingalpha.com/news/3346141-lakeland-industries-up-2-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3346141-lakeland-industries-up-2-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346167\" data-ts=\"1523978702\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346167-microsoft-facebook-among-tech-cos-signing-cybersecurity-tech-accord\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microsoft, Facebook among tech cos signing Cybersecurity Tech Accord</a></h4><ul><li>Microsoft (<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a> <font color='green'>+2.4%</font>) and Facebook (<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a> <font color='green'>+1.8%</font>) are <a href=\"https://www.reuters.com/article/us-usa-cyber-microsoft/tech-firms-including-microsoft-facebook-vow-not-to-aid-government-cyber-attacks-idUSKBN1HO283?feedType=RSS&amp;feedName=technologyNews&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FtechnologyNews+%28Reuters+Technology+News%29\" target=\"_blank\">among 30 tech companies</a> signing a pledge not to assist any government in offensive cyber attacks.</li><li>The Cybersecurity Tech Accord vows to protect customers from attacks regardless of the geopolitical or criminal motives of said attack.</li><li>The Accord also promises to establish new partnerships, both formal and informal, within the industry and among security researchers.</li><li>Other companies signing the pledge: Cisco (<a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a> <font color='green'>+2.6%</font>), Juniper Networks (<a href='https://seekingalpha.com/symbol/JNPR' title='Juniper Networks'>JNPR</a> <font color='green'>+1.1%</font>), Oracle (<a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a> <font color='green'>+1.5%</font>), Nokia (<a href='https://seekingalpha.com/symbol/NOK' title='Nokia Corporation'>NOK</a> <font color='green'>+4.2%</font>), SAP (<a href='https://seekingalpha.com/symbol/SAP' title='SAP AG'>SAP</a> <font color='green'>+1.5%</font>), Dell (DVMT <font color='green'>+0.9%</font>), Symantec (<a href='https://seekingalpha.com/symbol/SYMC' title='Symantec Corporation'>SYMC</a> <font color='green'>+1.3%</font>), and FireEye (<a href='https://seekingalpha.com/symbol/FEYE' title='FireEye, Inc.'>FEYE</a> <font color='red'>-0.4%</font>).</li><li>Microsoft President Brad Smith says, &ldquo;&ldquo;The devastating attacks from the past year demonstrate that cyber security is not just about what any single company can do but also about what we can all do together. This tech sector accord will help us take a principled path toward more effective steps to work together and defend customers around the world.&rdquo;</li><li>Related cyber security ETFs: <a href='https://seekingalpha.com/symbol/HACK' title='PureFunds ISE Cyber Security ETF'>HACK</a>, <a href='https://seekingalpha.com/symbol/CIBR' title='First Trust Nasdaq CEA Cybersecurity ETF'>CIBR</a>, <a href='https://seekingalpha.com/symbol/HAKK' title='Direxion Daily Cyber Security Bull 2x Shares ETF'>HAKK</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346167\" data-linked=\"Microsoft, Facebook among tech cos signing Cybersecurity Tech Accord\" data-tweet=\"$MSFT $MSFT $FB - Microsoft, Facebook among tech cos signing Cybersecurity Tech Accord https://seekingalpha.com/news/3346167-microsoft-facebook-among-tech-cos-signing-cybersecurity-tech-accord?source=tweet\" data-url=\"https://seekingalpha.com/news/3346167-microsoft-facebook-among-tech-cos-signing-cybersecurity-tech-accord\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346166\" data-ts=\"1523978583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWPH\" target=\"_blank\">GWPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346166-outlook-positive-for-gw-pharmas-cannabidiol-oral-solution-shares-up-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Outlook positive for GW Pharma&#39;s cannabidiol oral solution; shares up 10%</a></h4><ul><li>A review of the FDA advisory committee's <a href=\"https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM604736.pdf\" target=\"_blank\">briefing document</a> for Thursday's review of GW Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a> <font color='green'>+10.4%</font>) marketing application seeking approval for its cannabidiol oral solution for the treatment two rare types of epilepsy (LGS or DS) supports a positive vote backing approval. Selected points:</li><li><strong>Efficacy Conclusions </strong>(p. 14): Cites the positive results from three randomized placebo-controlled studies and says their design and endpoints \"are consistent with other studies that have been used to support drug approvals for epilepsy indications, including LGS.\" Adding, \"The statistically significant and clinically meaningful results from these three studies provide substantial evidence of the effectiveness of CBD (cannabidiol) for the treatment of seizures associated with LGS and DS.\"</li><li><strong>Safety </strong>(p. 24): \"in general, the risks associated with cannabidiol appeared to be acceptable.\" Liver risk should be manageable with appropriate labeling, prescriber education and monitoring of liver enzyme levels.</li><li><strong>Conclusions </strong>(p. 24): \"Although the review is still ongoing, the risk-benefit profile....appears to support approval....\"</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346136-ad-com-thursday-gw-pharmas-cannabidiol-oral-solution-types-epilepsy-shares-11-percent\" target=\"_blank\">Ad Com Thursday for GW Pharma's cannabidiol oral solution for types of epilepsy; shares up 11%</a> (April 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346166\" data-linked=\"Outlook positive for GW Pharma&#39;s cannabidiol oral solution; shares up 10%\" data-tweet=\"$GWPH - Outlook positive for GW Pharma&#39;s cannabidiol oral solution; shares up 10% https://seekingalpha.com/news/3346166-outlook-positive-for-gw-pharmas-cannabidiol-oral-solution-shares-up-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3346166-outlook-positive-for-gw-pharmas-cannabidiol-oral-solution-shares-up-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346165\" data-ts=\"1523978263\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QQQ\" target=\"_blank\">QQQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346165-tech-leads-big-gains-for-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tech leads more big gains for stocks</a></h4><ul><li>Amazon, Google, Microsoft, and Cisco are among the names&nbsp;<font color='green'>up 2% or more</font>, helping the Nasdaq (NASDAQ:<a href='https://seekingalpha.com/symbol/QQQ' title='Invesco QQQ ETF'>QQQ</a>) to a&nbsp;<font color='green'>1.5% advance</font>.</li><li>The S&amp;P 500 and DJIA are each&nbsp;<font color='green'>higher by 1%</font>, helped by General Electric's&nbsp;<font color='green'>3.4% move</font>.</li><li>Not working despite earnings beats this morning: Goldman Sachs and Johnson &amp; Johnson are each&nbsp;<font color='red'>down more than 1%</font>.</li><li>The 10-year Treasury yield is flat at 2.83%, and gold/oil are little-changed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346165\" data-linked=\"Tech leads more big gains for stocks\" data-tweet=\"$QQQ - Tech leads more big gains for stocks https://seekingalpha.com/news/3346165-tech-leads-big-gains-for-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3346165-tech-leads-big-gains-for-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346160\" data-ts=\"1523977235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHEK\" target=\"_blank\">CHEK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346160-healthcare-top-5-gainers-losers-of-11-00-04-17-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (04/17/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CHEK' title='Check-Cap Ltd.'>CHEK</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/ARDM' title='Aradigm Corp.'>OTC:ARDM</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/ASNS' title='Arsanis, Inc.'>ASNS</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/NVCR' title='NovoCure'>NVCR</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/APLS' title='Apellis Pharmaceuticals, Inc.'>APLS</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/BLCM' title='Bellicum Pharmaceuticals'>BLCM</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/AVXL' title='Anavex Life Sciences Corp.'>AVXL</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/VBLT' title='VBL Therapeutics'>VBLT</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/ATXI' title='Avenue Therapeutics'>ATXI</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346160\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (04/17/2018)\" data-tweet=\"$CHEK $CHEK $GWPH - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (04/17/2018) https://seekingalpha.com/news/3346160-healthcare-top-5-gainers-losers-of-11-00-04-17-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3346160-healthcare-top-5-gainers-losers-of-11-00-04-17-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346157\" data-ts=\"1523976525\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPI\" target=\"_blank\">SPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346157-spi-energyplus-15-on-bitcoin-mining-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SPI Energy +15% on bitcoin mining deal</a></h4><ul>     <li>SPI Energy (<a href='https://seekingalpha.com/symbol/SPI' title='SPI Energy Co., Ltd.'>SPI</a> <font color='green'>+15.4%</font>) surges after announcing an agreement with 500 IPO Fund base at Santa Clara, Calif., for 5,000 units of <a href=\"https://seekingalpha.com/pr/17131075-spi-energy-co-ltd-signed-strategic-agreement-500-ipo-fund-bitcoin-miner-hosting-service\" target=\"_blank\">bitcoin miner hosting services</a>.</li>     <li>SPI describes 500 IPO&nbsp;Fund as a \"dynamic venture capital ecosystem\" which \"connects China with Silicon Valley.\"</li>     <li>SPI <a href=\"https://seekingalpha.com/news/3322887-spi-energy-plus-150-percent-news-blockchain-based-infrastructure-division\" target=\"_blank\">said in January</a> that it had established a blockchain-based infrastructure application division in California.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346157\" data-linked=\"SPI Energy +15% on bitcoin mining deal\" data-tweet=\"$SPI - SPI Energy +15% on bitcoin mining deal https://seekingalpha.com/news/3346157-spi-energyplus-15-on-bitcoin-mining-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3346157-spi-energyplus-15-on-bitcoin-mining-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346145\" data-ts=\"1523974780\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LADR\" target=\"_blank\">LADR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346145-ladder-capital-down-7-after-related-walks-away\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ladder Capital down 7% after Related walks away</a></h4><ul><li>Ladder Capital (NYSE:<a href='https://seekingalpha.com/symbol/LADR' title='Ladder Capital Corp'>LADR</a>) earlier this year rejected a $15 per share buyout offer from Related Fund Management.</li><li><a href=\"https://seekingalpha.com/filing/3978082\" target=\"_blank\">In a filing last night</a>, Related says Ladder has refused to provide it with any more information that might allow for a boosted bid. It's thus withdrawing its proposal.</li><li>Ladder is<font color='red'> down 6.95%</font>&nbsp;to $13.94.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346145\" data-linked=\"Ladder Capital down 7% after Related walks away\" data-tweet=\"$LADR - Ladder Capital down 7% after Related walks away https://seekingalpha.com/news/3346145-ladder-capital-down-7-after-related-walks-away?source=tweet\" data-url=\"https://seekingalpha.com/news/3346145-ladder-capital-down-7-after-related-walks-away\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346142\" data-ts=\"1523974276\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSC-OLD\" target=\"_blank\">SSC-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346142-seven-stars-cloud-in-distribution-deal-gt-dollar-sharesplus-1_7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seven Stars Cloud in distribution deal with GT Dollar; shares +1.7%</a></h4><ul>   <li>Seven Stars Cloud (<a href=\"http://seekingalpha.com/symbol/SSC\" target=\"_blank\">SSC</a> <font color='green'>+1.7%</font>) has set a new <a href=\"https://seekingalpha.com/pr/17131875-seven-stars-cloud-announces-distribution-agreement-gt-dollar\" target=\"_blank\">digital asset distribution agreement</a> with Singapore's GT Dollar, gaining a built-in audience for digital financial products.</li>    <li>GTD plans a digital asset exchange and trade platform to facilitate listing, quotation, trading and settlement of SSC's digital index products.</li>    <li>GTD connects more than 2M businesses worldwide.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346142\" data-linked=\"Seven Stars Cloud in distribution deal with GT Dollar; shares +1.7%\" data-tweet=\"$SSC-OLD - Seven Stars Cloud in distribution deal with GT Dollar; shares +1.7% https://seekingalpha.com/news/3346142-seven-stars-cloud-in-distribution-deal-gt-dollar-sharesplus-1_7?source=tweet\" data-url=\"https://seekingalpha.com/news/3346142-seven-stars-cloud-in-distribution-deal-gt-dollar-sharesplus-1_7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346140\" data-ts=\"1523974266\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GS\" target=\"_blank\">GS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346140-goldman-cant-hold-post-earnings-gain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman can&#39;t hold post-earnings gain</a></h4><ul><li>A sharp rebound Goldman's (NYSE:<a href='https://seekingalpha.com/symbol/GS' title='Goldman Sachs Group Inc.'>GS</a>) beat-up trading operation led the bank to a sizable earnings beat in Q1, but investors aren't buying the news. \"The franchise does well when clients are active,\" says CFO Martin Chavez, speaking on the earnings call.</li><li>Other call comments from Chavez, however, might be behind the reversal in the share price this morning - Goldman, he says, <a href=\"https://www.zerohedge.com/news/2018-04-17/goldman-gives-early-gains-cfo-sees-no-buybacks-q2\" target=\"_blank\">will not be buying back </a>any stock in Q2.</li><li>The bank repurchased 3M shares in Q1 at an average price of $264.32 each. Tangible book value as of March 31 stood at $176.28. Shares are currently trading hands at $257,&nbsp;<font color='red'>down 0.35%</font>&nbsp;on the session.</li><li>Most of the rest of the financial sector (<a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> <font color='green'>+0.7%</font>) is in the green.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346050-trading-turnaround-helps-goldmans-q1-beat-shares-marginally\" target=\"_blank\">Trading turnaround helps Goldman's Q1 beat; shares down marginally</a> (April 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346140\" data-linked=\"Goldman can&#39;t hold post-earnings gain\" data-tweet=\"$GS $GS $XLF - Goldman can&#39;t hold post-earnings gain https://seekingalpha.com/news/3346140-goldman-cant-hold-post-earnings-gain?source=tweet\" data-url=\"https://seekingalpha.com/news/3346140-goldman-cant-hold-post-earnings-gain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346139\" data-ts=\"1523974104\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OTEX\" target=\"_blank\">OTEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346139-blue-harbours-robbins-says-open-text-sells-significant-discount\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blue Harbour&#39;s Robbins says Open Text sells at &quot;significant&quot; discount</a></h4><ul><li>        Blue Harbour&rsquo;s Cliff Robbins says Open Text (NASDAQ:<a href='https://seekingalpha.com/symbol/OTEX' title='Open Text Corporation'>OTEX</a>) takes share from IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) and has done well with acquisitions like its Documentum buy.</li><li>               Robbins says Open Text shares are mispriced and inexpensive with the current valuation a &ldquo;significant&rdquo; discount to its peers. Robbins sees the potential for 40% to 50% with the downside risk &ldquo;very muted.&rdquo;&nbsp;</li><li>               Blue Harbour owned 9.33M shares of Open Text as of December 31.&nbsp;</li><li>               Source: Bloomberg First Word.&nbsp;</li><li>               Open Text shares are&nbsp;<font color='green'>up 3.7%</font>&nbsp;to $35.82.&nbsp;</li><li>               IBM shares are&nbsp;<font color='green'>up 1%</font>&nbsp;to $159.44. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3346139\" data-linked=\"Blue Harbour&#39;s Robbins says Open Text sells at &quot;significant&quot; discount\" data-tweet=\"$OTEX $OTEX $IBM - Blue Harbour&#39;s Robbins says Open Text sells at &quot;significant&quot; discount https://seekingalpha.com/news/3346139-blue-harbours-robbins-says-open-text-sells-significant-discount?source=tweet\" data-url=\"https://seekingalpha.com/news/3346139-blue-harbours-robbins-says-open-text-sells-significant-discount\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346138\" data-ts=\"1523973812\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WWE\" target=\"_blank\">WWE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346138-wweminus-2_2-jpmorgan-heads-to-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WWE -2.2% as JPMorgan heads to sidelines</a></h4><ul>   <li>World Wrestling Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/WWE' title='World Wrestling Entertainment, Inc.'>WWE</a>) is <font color='red'>2.2% lower</font> after JPMorgan downgraded it to Neutral from Overweight.</li>    <li>\"We are comfortable moving to the sidelines\" given a risk/reward profile of -27%/+34%, says analyst David Karnovsky, who doesn't see a high enough step-up in rights fees, though he thinks NBCUniversal is interested in renewing. (h/t Bloomberg)</li>    <li>WWE is expected to to announce a new distribution deal later this year, with rights currently expiring in 2019.</li>    <li>The firm lifted its price target to $39 from $37; shares are at $38.62 currently.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346138\" data-linked=\"WWE -2.2% as JPMorgan heads to sidelines\" data-tweet=\"$WWE - WWE -2.2% as JPMorgan heads to sidelines https://seekingalpha.com/news/3346138-wweminus-2_2-jpmorgan-heads-to-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3346138-wweminus-2_2-jpmorgan-heads-to-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346136\" data-ts=\"1523973752\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWPH\" target=\"_blank\">GWPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346136-ad-com-thursday-for-gw-pharmas-cannabidiol-oral-solution-for-types-of-epilepsy-shares-up-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ad Com Thursday for GW Pharma&#39;s cannabidiol oral solution for types of epilepsy; shares up 11%</a></h4><ul><li>The FDA's Peripheral and Central Nervous System Drugs Advisory Committee will <a href=\"https://www.fda.gov/AdvisoryCommittees/Calendar/ucm597971.htm\" target=\"_blank\">meet </a>on Thursday, April 19, to discuss GW Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a> <font color='green'>+10.8%</font>) marketing application seeking approval for its cannabidiol oral solution for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients at least two years old.</li><li><a href=\"https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM604736.pdf\" target=\"_blank\">FDA briefing doc</a></li><li><a href=\"https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM604737.pdf\" target=\"_blank\">Errata to FDA briefing doc&nbsp;</a></li><li><a href=\"https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM604738.pdf\" target=\"_blank\">Company briefing doc</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3346136\" data-linked=\"Ad Com Thursday for GW Pharma&#39;s cannabidiol oral solution for types of epilepsy; shares up 11%\" data-tweet=\"$GWPH - Ad Com Thursday for GW Pharma&#39;s cannabidiol oral solution for types of epilepsy; shares up 11% https://seekingalpha.com/news/3346136-ad-com-thursday-for-gw-pharmas-cannabidiol-oral-solution-for-types-of-epilepsy-shares-up-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3346136-ad-com-thursday-for-gw-pharmas-cannabidiol-oral-solution-for-types-of-epilepsy-shares-up-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346128\" data-ts=\"1523972981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGEN\" target=\"_blank\">CGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346128-bayers-ildr2-inhibitor-shows-encouraging-action-in-preclinical-studies-discoverer-compugen-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bayer&#39;s ILDR2 inhibitor shows encouraging action in preclinical studies, discoverer Compugen up 4%</a></h4><ul><li>Compugen Ltd. (<a href='https://seekingalpha.com/symbol/CGEN' title='Compugen Ltd.'>CGEN</a> <font color='green'>+3.5%</font>) is up in early trade on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17131240-preclinical-data-presented-bayer-aacr-highlights-bay-1905254-formerly-cgenminus-15001t\" target=\"_blank\">announcement </a>that licensee Bayer AG (<a href='https://seekingalpha.com/symbol/BAYRY' title='Bayer A.G. ADR'>OTCPK:BAYRY</a> <font color='green'>+0.3%</font>) presented encouraging preclinical data on BAY 1905254 at the American Association for Cancer Research Annual Meeting in Chicago.</li><li>BAY 1905254, formerly CGEN-15001T, inhibits a protein called ILDR2 (immunoglobulin like domain containing receptor 2), a new immune checkpoint discovered by Compugen.</li><li>Preclinical work in mouse models showed anti-tumor activity as monotherapy and in combination with other cancer treatments. The first in-human studies should commence later this year.</li><li>Previously: <a href=\"https://seekingalpha.com/news/1192342-compugen-signs-development-deal-with-bayer-shares-soar\" target=\"_blank\">Compugen signs development deal with Bayer; shares soar</a> (Aug. 5, 2013)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346128\" data-linked=\"Bayer&#39;s ILDR2 inhibitor shows encouraging action in preclinical studies, discoverer Compugen up 4%\" data-tweet=\"$CGEN $CGEN $BAYRY - Bayer&#39;s ILDR2 inhibitor shows encouraging action in preclinical studies, discoverer Compugen up 4% https://seekingalpha.com/news/3346128-bayers-ildr2-inhibitor-shows-encouraging-action-in-preclinical-studies-discoverer-compugen-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3346128-bayers-ildr2-inhibitor-shows-encouraging-action-in-preclinical-studies-discoverer-compugen-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346125\" data-ts=\"1523972445\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVNW\" target=\"_blank\">AVNW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346125-aviat-networksplus-3_4-on-4_5m-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aviat Networks +3.4% on $4.5M project</a></h4><ul><li>        Aviat Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/AVNW' title='Aviat Networks, Inc.'>AVNW</a>) <a href=\"https://seekingalpha.com/pr/17131782-aviat-networks-awarded-new-4_5-million-project-large-nevada-county\" target=\"_blank\">announces</a> a new $4.5Mproject with a Nevada county government for first responder communications.</li><li>               Aviat Networks shares are&nbsp;<font color='green'>up 3.4%</font>&nbsp;to $17.89.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3346125\" data-linked=\"Aviat Networks +3.4% on $4.5M project\" data-tweet=\"$AVNW - Aviat Networks +3.4% on $4.5M project https://seekingalpha.com/news/3346125-aviat-networksplus-3_4-on-4_5m-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3346125-aviat-networksplus-3_4-on-4_5m-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346114\" data-ts=\"1523971498\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHPG\" target=\"_blank\">SHPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346114-fda-oks-expanded-use-for-shires-vonvendi-shares-up-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs expanded use for Shire&#39;s Vonvendi; shares up 2% premarket</a></h4><ul><li>Shire plc (NASDAQ:<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a>) is up&nbsp;<font color='green'>2%</font>&nbsp;premarket on light volume in response to the U.S. <a href=\"https://seekingalpha.com/pr/17131785-shire-plc-fda-approves-vonvendi-perioperative-management-bleeding-adult-patients-von\" target=\"_blank\">approval </a>for VONVENDI [von Willebrand factor (recombinant)] for the perioperative management of bleeding in adults with von Willebrand disease &#40;VWD&#41;, an inherited disorder characterized by slow blood clotting.</li><li>VONVENDI was first approved in the U.S. in December 2015 for the on-demand treatment and control of bleeding episodes in VWD adults.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346114\" data-linked=\"FDA OKs expanded use for Shire&#39;s Vonvendi; shares up 2% premarket\" data-tweet=\"$SHPG - FDA OKs expanded use for Shire&#39;s Vonvendi; shares up 2% premarket https://seekingalpha.com/news/3346114-fda-oks-expanded-use-for-shires-vonvendi-shares-up-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3346114-fda-oks-expanded-use-for-shires-vonvendi-shares-up-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346111\" data-ts=\"1523971246\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNET\" target=\"_blank\">CNET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346111-premarket-gainers-of-9-05-04-17-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (04/17/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/CNET' title='ChinaNet Online Holdings, Inc.'>CNET</a> <font color='green'>+66%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3346053-chinanet-online-reports-q4-results\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/CNIT-OLD' title='China Information Technology'>CNIT-OLD</a> <font color='green'>+8%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a> <font color='green'>+8%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a> <font color='green'>+8%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a> <font color='green'>+7%</font>&nbsp;on Q1&nbsp;<a href=\"https://seekingalpha.com/news/3345941-netflix-beats-0_01-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/ARQL' title='ArQule, Inc.'>ARQL</a> <font color='green'>+7%</font>&nbsp;on entering into an exclusive license <a href=\"https://seekingalpha.com/pr/17131221-arqule-basilea-enter-exclusive-license-agreement-derazantinib-us-eu-japan-rest-world\" target=\"_blank\">agreement</a> with Basilea Pharmaceuticals.</li>     <li><a href='https://seekingalpha.com/symbol/PUMP' title='ProPetro'>PUMP</a> <font color='green'>+7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3345988-five-propetro-changing-indexes-s-and-p-moves\" target=\"_blank\">joining </a>S&amp;P SmallCap 600.</li>     <li><a href='https://seekingalpha.com/symbol/ROKU' title='Roku Inc.'>ROKU</a> <font color='green'>+7%</font>&nbsp;as ESPN+ streaming <a href=\"https://seekingalpha.com/pr/17130769-espn-direct-consumer-subscription-streaming-service-now-available-roku-devices\" target=\"_blank\">services</a> on the Roku&nbsp;platform.</li>     <li><a href='https://seekingalpha.com/symbol/CGIX' title='Cancer Genetics, Inc.'>CGIX</a> <font color='green'>+4%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/GERN' title='Geron Corporation'>GERN</a> <font color='green'>+5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346111\" data-linked=\"Premarket Gainers as of 9:05 am (04/17/2018)\" data-tweet=\"$CNET $CNET $CNIT-OLD - Premarket Gainers as of 9:05 am (04/17/2018) https://seekingalpha.com/news/3346111-premarket-gainers-of-9-05-04-17-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3346111-premarket-gainers-of-9-05-04-17-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346106\" data-ts=\"1523970611\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LADR\" target=\"_blank\">LADR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346106-premarket-losers-of-9-05-4-17-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (4/17/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/LADR' title='Ladder Capital Corp'>LADR</a> <font color='red'>-9%</font>.</li><li><a href='https://seekingalpha.com/symbol/BLCM' title='Bellicum Pharmaceuticals'>BLCM</a>&nbsp;<font color='red'>-7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3345986-bellicum-pharmaceuticals-minus-6_9-percent-7m-share-public-offering\" target=\"_blank\">announcing</a> public offering of common stock.</li><li><a href='https://seekingalpha.com/symbol/AVXL' title='Anavex Life Sciences Corp.'>AVXL</a>&nbsp;<font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3346081-anavex-readies-mid-stage-study-lead-candidate-pdd-shares-ahead-2-percent-premarket\" target=\"_blank\">announcing</a> its plans to initiate a Phase 2 trial evaluating ANAVEX 2-73 in patients with PDD.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3346106\" data-linked=\"Premarket Losers as of 9:05 am (4/17/2018)\" data-tweet=\"$LADR $LADR $BLCM - Premarket Losers as of 9:05 am (4/17/2018) https://seekingalpha.com/news/3346106-premarket-losers-of-9-05-4-17-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3346106-premarket-losers-of-9-05-4-17-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346105\" data-ts=\"1523970582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNOA\" target=\"_blank\">SNOA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346105-sonoma-pharma-secures-regulatory-approvals-for-four-products-in-uae-shares-up-5-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sonoma Pharma secures regulatory approvals for four products in the UAE; shares up 5% premarket</a></h4><ul><li>Thinly traded nano cap Sonoma Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SNOA' title='Sonoma Pharmaceuticals, Inc.'>SNOA</a>) is up&nbsp;<font color='green'>5%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17131290-sonoma-pharmaceuticals-receives-four-new-uae-regulatory-approvals-include-acne-anti-fungal\" target=\"_blank\">announcement </a>that the United Arab Emirates &#40;UAE&#41; Ministry of Health &amp; Prevention has approved four new acne and anti-fungal products there.</li><li>Exclusive distributor MicroSafe Group says the products will be immediately available in UAE pharmacies.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346105\" data-linked=\"Sonoma Pharma secures regulatory approvals for four products in the UAE; shares up 5% premarket\" data-tweet=\"$SNOA - Sonoma Pharma secures regulatory approvals for four products in the UAE; shares up 5% premarket https://seekingalpha.com/news/3346105-sonoma-pharma-secures-regulatory-approvals-for-four-products-in-uae-shares-up-5-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3346105-sonoma-pharma-secures-regulatory-approvals-for-four-products-in-uae-shares-up-5-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346101\" data-ts=\"1523970244\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XCRA\" target=\"_blank\">XCRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346101-needham-upgrades-xcerra-to-28-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham upgrades Xcerra to 28% upside</a></h4><ul><li>        Needham upgrades Xcerra (NASDAQ:<a href='https://seekingalpha.com/symbol/XCRA' title='Xcerra Corporation'>XCRA</a>) from Hold to Buy with a $16 price target, a 28% upside to yesterday&rsquo;s close.</li><li>               Firm cites the expected upside to estimates, Xcerra&rsquo;s participation in long-term secular growth in the auto/industrial markets, and the current low valuation.&nbsp;</li><li>               Needham was previously concerned about slower Y/Y growth in the near-term but now sees solid growth in Semi Test supported by TAM expansion and new products.&nbsp;</li><li>               Source: Briefing.com.&nbsp;</li><li>               XCRA shares are&nbsp;<font color='green'>up 3.5%</font>&nbsp;premarket to $12.95.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3346101\" data-linked=\"Needham upgrades Xcerra to 28% upside\" data-tweet=\"$XCRA - Needham upgrades Xcerra to 28% upside https://seekingalpha.com/news/3346101-needham-upgrades-xcerra-to-28-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3346101-needham-upgrades-xcerra-to-28-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346097\" data-ts=\"1523970078\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RKDA\" target=\"_blank\">RKDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346097-acadia-advancing-reduced-gluten-wheat-shares-ahead-8-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acadia advancing reduced-gluten wheat; shares ahead 8% premarket</a></h4><ul><li>Arcadia Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/RKDA' title='Arcadia Biosciences'>RKDA</a>) is up&nbsp;<font color='green'>8%&nbsp;</font>premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17131389-arcadia-biosciences-expands-goodwheat-portfolio-reduced-gluten-wheat\" target=\"_blank\">announcement </a>that it plans to add its new reduced gluten wheat lines to its GoodWheat portfolio of branded ingredients. The first bread flour should be available for commercial testing by year-end.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346097\" data-linked=\"Acadia advancing reduced-gluten wheat; shares ahead 8% premarket\" data-tweet=\"$RKDA - Acadia advancing reduced-gluten wheat; shares ahead 8% premarket https://seekingalpha.com/news/3346097-acadia-advancing-reduced-gluten-wheat-shares-ahead-8-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3346097-acadia-advancing-reduced-gluten-wheat-shares-ahead-8-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346093\" data-ts=\"1523969508\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUTR\" target=\"_blank\">CUTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346093-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Cutera (NASDAQ:<a href='https://seekingalpha.com/symbol/CUTR' title='Cutera, Inc.'>CUTR</a>) initiated with Hold rating and $55 (flat) price target at Stifel.</li><li>Viveve Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/VIVE' title='Viveve Medical, Inc.'>VIVE</a>) initiated with Buy rating and $6 (79% upside) price target at Stifel.</li><li>Intricon (NASDAQ:<a href='https://seekingalpha.com/symbol/IIN' title='IntriCon Corporation'>IIN</a>) initiated with Buy rating and $35 (79% upside) price target at Stifel.</li><li>Allergan (NYSE:<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a>) initiated with Hold rating and $192 (15% upside) price target at Stifel.</li><li>Merck (NYSE:<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a>) upgraded to Overweight at Morgan Stanley. Shares up&nbsp;<font color='green'>2%&nbsp;</font>premarket.</li><li>Bristol-Myers Squibb (NYSE:<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a>) downgraded to Equal Weight at Morgan Stanley. Shares up a fraction premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346093\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$CUTR $CUTR $VIVE - Premarket analyst action - healthcare https://seekingalpha.com/news/3346093-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3346093-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346089\" data-ts=\"1523968993\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTI\" target=\"_blank\">PTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346089-tdn-on-board-proteostasis-mid-stage-study-of-cystic-fibrosis-candidate-ptiminus-428\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TDN on board with Proteostasis&#39; mid-stage study of cystic fibrosis candidate PTI-428</a></h4><ul><li>Proteostasis Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics'>PTI</a>) is up&nbsp;<font color='green'>6%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17131297-proteostasis-receives-endorsement-cystic-fibrosis-foundations-therapeutic-development-network\" target=\"_blank\">announcement </a>that the Therapeutics Development Network &#40;TDN&#41;, the drug development arm of the Cystic Fibrosis Foundation, has endorsed its Phase 2 clinical trial assessing CFTR amplifier PTI-428.</li><li>The TDN endorsement provides access to 89 accredited care centers in the U.S.</li><li>CEO Meenu Chhabra says, \"We believe PTI-428 holds the promise of improving treatment efficacy for currently underserved segments of the CF population, as well as for those who have experienced a decline in lung function over time while on Orkambi. We are grateful and humbled to receive TDN endorsement for this latest study of PTI-428 and we plan to start dosing CF patients in the third quarter of this year. We aim to share initial results in early 2019. This study will allow us to broaden the planned pivotal trial next year that includes subjects on either Orkambi or Symdeko background therapy.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3346089\" data-linked=\"TDN on board with Proteostasis&#39; mid-stage study of cystic fibrosis candidate PTI-428\" data-tweet=\"$PTI - TDN on board with Proteostasis&#39; mid-stage study of cystic fibrosis candidate PTI-428 https://seekingalpha.com/news/3346089-tdn-on-board-proteostasis-mid-stage-study-of-cystic-fibrosis-candidate-ptiminus-428?source=tweet\" data-url=\"https://seekingalpha.com/news/3346089-tdn-on-board-proteostasis-mid-stage-study-of-cystic-fibrosis-candidate-ptiminus-428\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346082\" data-ts=\"1523968200\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNST\" target=\"_blank\">MNST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346082-goldman-sachs-taps-monster-beverage-sector-fav\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman Sachs taps Monster Beverage as sector fav</a></h4><ul> <li>Goldman Sachs analyst Judy Hong <a href=\"https://www.cnbc.com/2018/04/17/goldman-sachs-upgrades-coca-cola-downgrades-pepsi.html\" target=\"_blank\">calls</a> Monster Beverage (NASDAQ:<a href='https://seekingalpha.com/symbol/MNST' title='Monster Beverage Corp.'>MNST</a>) her favorite pick in the U.S. beverage sector due to the potential for international growth.</li> <li>The bullish call on Monster stands in contrast to a warning from Hong and team on consumer staples in general due to rising interest rates.</li> <li>Shares of MNST are&nbsp;<font color='green'>up 0.61%</font>&nbsp;in premarket trading. The stock has been an ouperformer in the beverage sector over the last 52 weeks with a 26% gain.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3346082\" data-linked=\"Goldman Sachs taps Monster Beverage as sector fav\" data-tweet=\"$MNST - Goldman Sachs taps Monster Beverage as sector fav https://seekingalpha.com/news/3346082-goldman-sachs-taps-monster-beverage-sector-fav?source=tweet\" data-url=\"https://seekingalpha.com/news/3346082-goldman-sachs-taps-monster-beverage-sector-fav\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346081\" data-ts=\"1523968106\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVXL\" target=\"_blank\">AVXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346081-anavex-readies-mid-stage-study-of-lead-candidate-in-pdd-shares-ahead-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anavex readies mid-stage study of lead candidate in PDD; shares ahead 2% premarket</a></h4><ul><li>Anavex Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/AVXL' title='Anavex Life Sciences Corp.'>AVXL</a>) is up&nbsp;<font color='green'>2%</font>&nbsp;premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/17131296-anavex-life-sciences-initiate-phase-2-study-anavex-2minus-73-parkinson-s-disease-dementia\" target=\"_blank\">announcement </a>that it plans to initiate a Phase 2 clinical trial evaluating lead candidate ANAVEX 2-73 in patients with Parkinson's Disease Dementia &#40;PDD&#41;. The study should launch in H2.</li><li>Another Phase 2 in Rett syndrome should commence in H2 as well.</li><li>Orally available&nbsp;<a href=\"http://www.anavex.com/pipeline/anavex-2-73/\" target=\"_blank\">ANAVEX 2-73</a>&nbsp;is a sigma-1 receptor (S1R) agonist. S1Rs play a key role in the modulation of neurotransmission.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346081\" data-linked=\"Anavex readies mid-stage study of lead candidate in PDD; shares ahead 2% premarket\" data-tweet=\"$AVXL - Anavex readies mid-stage study of lead candidate in PDD; shares ahead 2% premarket https://seekingalpha.com/news/3346081-anavex-readies-mid-stage-study-of-lead-candidate-in-pdd-shares-ahead-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3346081-anavex-readies-mid-stage-study-of-lead-candidate-in-pdd-shares-ahead-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346068\" data-ts=\"1523967124\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACIA\" target=\"_blank\">ACIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346068-acacia-communicationsminus-1_3-on-analyst-downgrade-due-to-zte-ban\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acacia Communications -1.3% on analyst downgrade due to ZTE ban</a></h4><ul><li>        Bank of America Merrill Lynch downgrades Acacia Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/ACIA' title='Acacia Communications'>ACIA</a>) from Neutral to Buy and drops the price target from $46 to $28.</li><li>               Analyst Tal Liani says there might be a 30% or higher downside to revenue estimates after the new U.S. ban on exports to ZTE.&nbsp;</li><li>               BofAML&rsquo;s previous Buy thesis was based on a ZTE/China-based rebound this year.&nbsp;</li><li>               Analyst says shares might &ldquo;trade sideways&rdquo; until investors have clarity.&nbsp;</li><li>               Source: Bloomberg First Word.&nbsp;</li><li>               Acacia Communications shares are&nbsp;<font color='red'>down 1.3%</font>&nbsp;premarket to $25.30.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3346068\" data-linked=\"Acacia Communications -1.3% on analyst downgrade due to ZTE ban\" data-tweet=\"$ACIA - Acacia Communications -1.3% on analyst downgrade due to ZTE ban https://seekingalpha.com/news/3346068-acacia-communicationsminus-1_3-on-analyst-downgrade-due-to-zte-ban?source=tweet\" data-url=\"https://seekingalpha.com/news/3346068-acacia-communicationsminus-1_3-on-analyst-downgrade-due-to-zte-ban\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346060\" data-ts=\"1523966687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTAP\" target=\"_blank\">NTAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346060-analyst-upgrades-netapp-shares-trading-52-week-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analyst upgrades NetApp; shares trading at 52-week high</a></h4><ul><li>        William Blair <a href=\"https://www.streetinsider.com/Upgrades/William+Blair+Upgrades+NetApp+%28NTAP%29+to+Outperform%2C+The+Surge+Looks+Sustainable/14060888.html\" target=\"_blank\">upgrades</a> NetApp (NASDAQ:<a href='https://seekingalpha.com/symbol/NTAP' title='NetApp, Inc.'>NTAP</a>) from Market Perform to Outperform.</li><li>               Latest analyst <a href=\"https://markets.ft.com/data/equities/tearsheet/forecasts?s=NTAP:NSQ\" target=\"_blank\">recommendations</a>: 6 Buy, 10 Outperform, 15 Hold, and 1 Sell.&nbsp;</li><li>                  Median price target: $73.    </li><li>               NetApp shares are&nbsp;<font color='green'>up 0.9%</font>&nbsp;premarket to $68.88 with the previous 52-week range of $37.43 to $68.79.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3346060\" data-linked=\"Analyst upgrades NetApp; shares trading at 52-week high\" data-tweet=\"$NTAP - Analyst upgrades NetApp; shares trading at 52-week high https://seekingalpha.com/news/3346060-analyst-upgrades-netapp-shares-trading-52-week-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3346060-analyst-upgrades-netapp-shares-trading-52-week-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}